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The multiple etiologies of schizophrenia prompt us to raise the question: what final com-
mon pathway can induce a convincing sense of the reality of the hallucinations in this
disease? The observation that artificial stimulation of an intermediate order of neurons of
a normal nervous system induces hallucinations indicates that the lateral entry of activity
(not resulting from canonical synaptic transmission) at intermediate neuronal orders may
provide a mechanism for hallucinations. Meaningful hallucinations can be de-constructed
into an organized temporal sequence of internal sensations of associatively learned items
that occur in the absence of any external stimuli. We hypothesize that these hallucinations
are autonomously generated by the re-activation of pathological non-specific functional
LINKs formed between the postsynaptic membranes at certain neuronal orders and are
examined as a final common mechanism capable of explaining most of the features of the
disease. Reversible and stabilizable hemi-fusion between simultaneously activated adja-
cent postsynaptic membranes is viewed as one of the normal mechanisms for functional
LINK formation and is dependent on lipid membrane composition. Methods of removing
the proteins that may traverse the non-specifically hemi-fused membrane segments and
attempts to replace the phospholipid side chains to convert the membrane composition to
a near-normal state may offer therapeutic opportunities.
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INTRODUCTION
Schizophrenia has been viewed as a neuro-developmental disorder
(McGorry et al., 2008; Insel, 2010) with stages of pre-symptomatic
risk, pre-psychotic prodrome, acute psychosis, and chronic illness,
where the last two stages present with delusions, hallucinations,
negative symptoms, cognitive alterations, and affective dysregula-
tion (van Os et al., 2010). It is also thought that mental illnesses
are determined by their effect on the conscious representational
Abbreviations: AA, arachidonic acid; ACBP, acyl coenzyme A binding protein; ALA,
alpha-linolenic acid; ApoB, apolipoprotein B; CA3, cornu ammonis layer 3, is a
layer of neurons in the hippocampus; COMT, catechol o-methyl transferase; COX-
1, cyclooxygenase-1; CPT-1, carnitine palmitoyl transferase-1; DAG, diacyl glycerol;
DGLA, dihomo gamma-linolenic acid; DHA, docosa-hexaenoic acid; DOPA, 3,4-
dihydroxyphenylalanine. It is a neurotransmitter; DPA, docosapentaenoic acid; EFA,
essential fatty acids. There cannot be synthesized in the body and should be available
from the diet; EPA, eicosapentaenoic acid; EPSP, excitatory postsynaptic potentials.
These are potentials developed at the postsynaptic membranes when an excita-
tory synapse is activated; GABA, gama amino butyric acid. This is an inhibitory
neurotransmitter; HDL, high density lipoprotein; IP3, inositol 1,4,5-trisphosphate;
Islets, islets of functionally LINKed postsynaptic membranes; KMO, kynurenine
3-monooxygenase; LA, linoleic acid; LCAT, lecithin cholesterol acyl transferase;
LDL, low density lipoprotein; LINK, link between the postsynapses. The words
are capitalized to show its importance. Inter-postsynaptic membrane hemi-fusion
is explained as a possible mechanism; LPC, lysophosphatidyl choline; LPL, lipopro-
tein lipase; LTP, long-term potentiation, an electro-physiological finding that has
many correlations with memory; MRI, magnetic resonance imaging; NMDA, N -
methyl d-aspartate, a chemical that specifically bind to a receptor subtype of
excitatory glutamate receptors; NR1/NR2B, subunits of NMDA receptor; PC, phos-
phatidyl choline; PE, phosphatidyl ethanolamine; PIP2, phosphatidylinositol 4,5-
bisphosphate; PLA2, phospholipase A2; Postsynapses, postsynaptic membranes or
dendritic spines; PUFA, polyunsaturated fatty acids; SNAP, synaptosomal-associated
protein; VLDL, very low density lipoprotein; ω-3, omega-3.
experience (Graham and Stephens, 2007). The features of schizo-
phrenia are known to manifest across all domains of conscious-
ness, namely subjective experience, expression, cognition, affect,
behavior, and will (Parnas, 2011), necessitating an explanation
for all its different features that stems from alterations of a basic
mechanism related to the formation of an internal sense of con-
sciousness. Antipsychotics that reduce delusions and hallucina-
tions (Harvey et al.,2010) do not enhance functional recovery from
treatment-refractory cognitive deficits of attention and working
memory (Insel, 2010). Due to the difficulties in explaining the
patho-physiology of the cognitive defects (Holden, 2003), empha-
sis has been placed on using knowledge from research work on
Alzheimer’s disease (Insel, 2010). Even with all these challenges,
there is optimism about the discovery of the neural mechanisms
that produce mental experiences (Thagard, 2008).
The nature of the elements contributing to the normal func-
tioning of any complex system may be understood by examining its
disease states. However, results from a large number of genomic
studies indicate the possibility of a large variety of lesions lead-
ing to the prospect that this disease may consist of many different
disorders (Kirkpatrick et al., 2001). Varying etiologies of this disor-
der, including developmental trauma, incidence in minority racial
groups, upbringing in an urban environment, and cannabis use,
make study of the disorder challenging (van Os et al., 2010). A
framework of the disease process is expected to provide an expla-
nation for the positive symptom of hallucinations, the negative
symptom of catatonia, cognitive impairment, relief from hallu-
cinations by D2 receptor antagonists, involvement of the disease
across all the domains of consciousness, a concordance rate of
the disease close to 50% in monozygotic twins, manifestation of
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the symptoms starting in the teenage period, and schizophrenia-
like symptoms in hyper-dopaminergic and N -methyl-d-aspartate
(NMDA) receptor-blocking conditions. In these contexts, the con-
trasting but complementary pieces of the disease puzzle may
provide clues to understanding the pathology and verifying the
operating mechanisms for internal sensations of higher brain
functions. An abstract of this work was presented at the Society
for Neuroscience annual meeting in 2009 (Vadakkan, 2009).
FROM ARTIFICIAL INDUCTION OF HALLUCINATIONS TO MECHANISM
OF INTERNAL SENSATIONS
Artificial stimulation of neurons within the nervous system can
induce different hallucinations (Selimbeyoglu and Parvizi, 2010).
Electrical stimulation of the medial temporal lobe can cause vivid
experiences of autobiographic memories (Vignal et al., 2007). Hip-
pocampal activation is associated with the actual experience of
auditory (Shergill et al., 2000) or visual hallucinations along with
activation in higher-order neocortical areas (Oertel et al., 2007).
This supports the view that hippocampal hyperactivity might
underlie hallucinations and other positive symptoms in schizo-
phrenia (Lodge and Grace, 2007). These findings also indicate that
the lateral entry of activity arising autonomously from pathologi-
cal changes activates intermediate orders of neurons, mis-directing
the route of the normal train of internal sensations throughout
the nervous system and evoking hallucinations with a compelling
sense of reality.
Even though auditory hallucinations are predominant, visual
hallucinations are also reported in schizophrenia (David et al.,
2011). Since the neuronal orders in the visual pathway are well
characterized, we examine the nature of the hallucinations occur-
ring from different pathologies along the visual pathway to under-
stand the nature of their processing. From Table 1, it can be
seen that as the location of pathologies causing the lateral entry
of activity moves toward higher neuronal orders, the hallucina-
tions become more non-stereotypical and involve a more dynamic
sequence of events.
INTERNAL SENSATION OF HALLUCINATIONS AND RETRIEVED
MEMORIES
The observation that both hallucinations and cognitive defects
occur with hippocampal pathologies (Vignal et al., 2007) leads to
the expectation that the internal sensations of meaningful halluci-
nations and retrieved memories may share a common mechanism.
Hallucinations are viewed as phenomenologically closely related
to conscious perception (Llinas and Pare, 1991; Behrendt, 2010)
and share some common mechanisms with the conscious recol-
lection of autobiographical memories (Behrendt, 2010). Another
view is that hallucinations differ from conscious perceptions only
with regard to the extent to which they are constrained by exter-
nal physical reality; therefore, understanding the mechanism of
any one conscious experience is expected to aid in understanding
the mechanism of all of them (Uhlhaas and Singer, 2010). Unlike
hallucinations caused by most of the pathologies in Table 1 that
are generally perceived as unreal by the subjects, the content of
hallucinations in schizophrenia is highly meaningful, with a com-
pelling sense of reality (Linn, 1977; Birchwood et al., 2000). These
features bring forth three key implications. (a) The convincing
nature of the internal sensation of hallucination implies that the
operation of the entire system is affected such that there are no
separate functioning areas that can identify the hallucinations as
unreal. (b) The autonomous nature of hallucinations indicates that
at certain neuronal orders, pathologies exist to evoke a continu-
ous flow of these internal sensations. (c) The meaningful and real
nature of hallucinations indicates that the system is utilizing the
Table 1 | List of diseases, nature of visual hallucinations, and possible neuronal orders affected.
Location Nature of hallucinations Neuronal order
Retina and choroid (Siatkowski et al., 1990; Holroyd et al., 1992) Flickering flashes of light 1
Vitreal detachment (Schmidt et al., 1996) Brief vertical flashes of light 1
Optic neuritis (Davis et al., 1976) Spontaneous flashes of light 1
Occipital epilepsy (Panayiotopoulos, 1994) Brief, stereotyped, fragmentary, and multi-colored lines
of simple patterns
∼2–5
Occipito-temporal ictal (Young et al., 1989) Palinopsia (image recurs immediately after gaze
diversion)
∼3–6
Fusiform gyrus activation (Cardoso et al., 2010) Hallucinations in color ∼3–6
Focal seizures of temporal lobe (Bancaud et al., 1994) Deja vu, jamais vu ∼4–8
Diffuse Lewy body disease (O’Brien et al., 2005) Vivid visual hallucinations: colorful and complex involving
scenes of people and animals
Many?
Schizophrenia (David et al., 2011) Convincing sense of reality with lack of stereotypy
(contents vary)
Many?
It is observed that the higher the neuronal orders at which lateral entry of activity occurs, the more well-formed, non-stereotypical, and convincing are the hallucinations
produced.
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normal operational mechanism of internal sensations of memory
retrieval beyond the locations of the pathological changes.
EXAMINATION OF INTERNAL SENSATIONS
Internal sensations vary from simple sensations of the form of
an item in an environment to complex sensations of emotions.
The present work examines how associated information from the
environment is encoded and internal sensations of their memo-
ries are formed at a later time point. Since the artificial stimulation
of neurons at an intermediate order can induce different halluci-
nations (Selimbeyoglu and Parvizi, 2010), it can be assumed that
pathological conditions inducing the non-specific lateral entry of
activity can mis-direct the higher orders of the system to induce
an organized temporal sequence of meaningful hallucinations that
can explain the symptoms of schizophrenia. The shared elements
of the same mechanism should also be able to explain the cognitive
defects.
The nervous system, with its finite types of sensory systems and
finite number of sensory receptors in each system, receives simul-
taneous sensory inputs to more than one sensory system from
an item (“item” means anything that relates to the real world)
in the environment. As the distance between the sensory recep-
tors and the item increases, the sensory input traveling at the
highest velocity reaches the nervous system faster than the oth-
ers (Figure 1). The ability to form internal sensations of slowly
approaching sensory inputs or inputs that may never reach the
nervous system can provide a survival advantage. When an item
is very close to an animal, the simultaneous arrival of multi-
ple sensory inputs should make changes in the nervous system
so that at a later time when the fastest sensory stimulus arrives
alone at the sensory receptors, it creates the semblance of the
remaining sensory inputs from the item. A nervous system with
this mechanism is expected to build several such operational
units during its life-span. At the instance of the arrival of new
combinations of sensory stimuli, new combinations of internal
sensations can be created, the extent and complexity of which
can possibly create complex higher brain functions, including
emotions.
REDUCING THE INTERNAL SENSATION OF MEMORY OF AN EVENT
Hallucinations induced by the stimulation of an intermediate path
by pathological irritation are expected to share some basic features
with that of memory retrieval. What kind of reductive approach
FIGURE 1 |The nervous system utilizes the early arriving sensations to
create the internal sensations of late-arriving or non-arriving sensory
stimuli. The sight of lightning provides the impression that a sound is likely
to follow. This property allows the nervous system to anticipate the internal
sensations of the remaining sensory stimuli and prepares it to execute
motor actions for survival.
is required to understand the nature of the internal sensations
within the nervous system? An episodic representation of an event
is organized into an order of events that unfolds as a mental replay
of the event spread over time (Tulving, 2002). Internal sensations
of memory for each event can be de-constructed into a series of
associative representations of the learned items or events. What
basic mechanism at the cellular level can induce changes at the
time of associative learning that can be used to evoke the virtual
internal sensation of the learned item at the time of memory
retrieval? What type of basic unitary structure or its alterations can
induce hallucinations of certain sensory stimuli arriving through
its preceding neuronal orders and ultimately from the environ-
ment,when an intermediate path is activated through lateral entry?
A summary of the previously described mechanism (Vadakkan,
2011) is given below.
A novice nervous system consists of synaptically connected
neurons, each with varying lengths of dendrites and axonal termi-
nals, arranged in various neuronal orders. On average, a neuron
has 2.4–8× 104 dendritic spines (postsynapses or postsynaptic
membranes) on its dendritic tree (Abeles, 1991) where excitatory
postsynaptic potentials (EPSPs) can be induced, provided activity
arrives at their corresponding presynaptic terminals (presynapses
or dendritic spines). The spatial summation of EPSPs from nearly
40 dendritic spines or the temporal summation of EPSPs from
fewer than 40 dendritic spines can evoke an action potential at
the neuron’s axonal hillock. When the item is close to the ani-
mal, different sensory stimuli from the item pass through different
neuronal orders and converge at certain neuronal orders. Let us
imagine that certain functional LINKs (the letters are capitalized to
denote its significance) are formed between two sensory pathways
at the locations of their convergence, during associative learning,
that can be re-activated by one of the stimuli during memory
retrieval. What is an ideal neuronal location for the formation of
such a functional LINK between two converging stimulus-induced
activities?
The ideal site should be a sub-cellular location where re-
activation of the functional LINK by one of the associatively
learned sensory stimuli should be capable of evoking a basic unit of
internal sensation of the second stimulus. The structural equiva-
lent of such a LINK should be able to activate the neuronal pathway
of the second stimulus at the location of the functional LINK.
Moreover, the induced activity at the second pathway should not
travel in a retrograde direction. Therefore, the ideal location for
the functional LINK is between the postsynaptic membranes at
the location of convergence of the two stimuli (Figure 2). Activ-
ity reaching the second postsynapse (postsynapse D, Figure 3)
through the re-activation of the functional LINK, without any
activity arriving from its corresponding presynapse (presynaptic
terminal C, Figure 3), induces a normal cellular (physiological)
semblance of activity arriving from its presynapse (presynaptic
terminal C, Figure 3). The basic units of hypothetical packets
of sensory inputs of this physiological semblance at the second
postsynapse (postsynapse D in Figure 3) are called semblions
(Vadakkan, 2011). This is hypothesized to occur as an intrinsic
property of systems in which neurons at certain orders [in the cor-
tex and hippocampus (Buzsaki, 1996)] undergo oscillating activity
(derivation given in Figure 3).
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FIGURE 2 | Potential changes between the postsynapses during
associative learning that are later used to induce internal sensation of
associatively learned items. (A) The illustration shows functional LINK
formation between the two postsynaptic membranes B and D during
learning. The functional LINK is transient and its formation is a function of
the simultaneous activation of postsynapses B and D. A and C are the
corresponding presynapses. (B) At a later time, when one the stimuli
arrives, the functional LINK is re-activated, resulting in the activation of
postsynaptic membrane D inducing the semblance of activity arriving from
presynapse C. It is required to maintain the functional LINK in a re-activable
state during the interval of time from associative learning to the exposure
to one of the stimuli. [Figure was used after modification (Vadakkan, 2011)].
Since physical properties of different items in a given environ-
ment share certain common features and since each item in the
environment can provide multiple sensory stimuli, different items
can stimulate overlapping sets of sensory receptors. Therefore, we
expect a large number of inter-postsynaptic functional LINKs to
be shared; their number increases as the nervous system is exposed
to an increasing number of items during different associative
learning events in life. Multiple instances of associative learning
lead to the formation of groups of functionally LINKed postsy-
napses that are called islets (Figure 4). During memory retrieval,
this enables the spread of activity within the islet to form sem-
blances of associatively learned related sensory inputs, presenting
the common physical properties characteristic of an environment.
The net semblances from all the postsynapses at various orders of
neurons finally determine the nature of the internal sensations.
Repeated re-activation of the commonly used functional LINKs
may induce cellular changes to maintain them as near-structural
LINKs.
FAILURE TO KEEP THE ISLETS SEPARATE CAN INDUCE AUTONOMOUS
HALLUCINATIONS
Keeping the islets of functionally LINKed postsynapses sepa-
rate from each other is crucial for maintaining the specificity
of formed semblances in response to a cue stimulus. Therefore,
we can reasonably expect that the formation of any non-specific
inter-postsynaptic hemi-fusion may lead to the formation of
non-specific semblances during memory retrieval. If this hemi-
fusion occurs between single postsynapses, then the net non-
specificity of semblances from all the neuronal orders will be
comparatively small. However, non-specific LINKs between the
postsynapses that are part of large islets of functionally LINKed
postsynapses can produce a large reduction in the specificity of
semblances at the level of that neuronal order resulting in cognitive
FIGURE 3 | When the cue stimulus activates synapse A-B, the
previously formed functional LINK between postsynapses B and D is
re-activated. Lateral entry of activity activating postsynapse D without
receiving activity from presynaptic terminal C evokes a cellular semblance
of an action potential reaching from its presynaptic terminal C, which is
called synaptic semblance. The nature of the semblance is derived as
follows. Postsynapse D experiences the cellular semblance that it is
receiving inputs from the set of neurons {Y} that synapse to the neuron Z of
its presynapse C. The set of neurons {Y} is activated by the set of neurons
{X}, which in turn is activated by the set of neurons {W}. Continuing this
extrapolation toward the sensory level identifies a set of sensory receptors
{SR}. The nature of the semblance depends on the sensory stimuli that
would activate the receptor set {SR}. The stimulation of subsets of sensory
receptor sets {sr1}, {sr2}, and {sr3} of the set {SR} may be capable of
independently activating neuron Z. The dimensions of hypothetical packets
of sensory stimuli capable of activating the sensory receptor subsets {sr1},
{sr2}, and {sr3} are called semblions 1, 2, and 3 respectively and are viewed
as the basic building blocks of the virtual internal sensations of memory.
The identities of the cue-activated semblances from different postsynapses
at each order of neurons (by combination) and the temporal formation of
semblances (due to synaptic delay) at different orders of neurons (by
permutation) can become integrated to provide the virtual sensation of a
sensory stimulus during memory retrieval. Neuronal oscillations and the
background sensory inputs result in the summation of EPSPs to only
sub-threshold levels in many neurons, short of eliciting action potentials
(neuron N2 before the arrival of the cue stimulus). Arrival of the cue
stimulus re-activates the functional LINK and activates postsynapse D.
When this potential is added to the sub-threshold EPSPs, some neurons
(for example, neuron N2) trigger action potential. Thus, the formation of
semblances at the functionally LINKed postsynapses may explain the
concurrent activation of certain neurons (Reijmers et al., 2007;
Gelbard-Sagiv et al., 2008; Tye et al., 2008) by specific cue stimuli during
memory retrieval that are likely the neurons that are currently thought to
represent memories [Figure was used after modification (Vadakkan, 2011)].
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FIGURE 4 | Illustration showing functional LINK formation
between the postsynaptic membranes (postsynapses or dendritic
spines). (A) A group of six synapses are shown close to each other
with their postsynapses LINKed by functional LINKs from previous
associative learning events. The circular ring shows a cross-section
made across the islet of these functional LINKs at the level of the
postsynapses. (B) Postsynaptic membranes are shown in small circles
(broken arrow). Functionally LINKed postsynapses form islets of
functionally LINKed postsynapses (solid arrow). (C) Semblances S1 and
S2 formed from two islets I1 and I2 respectively when they are
depolarized separately by different cue stimuli during memory retrieval.
It is required to maintain the islets of functionally LINKed postsynapses
separate and isolated to induce specific semblances by different cue
stimuli [Figure was used after modification (Vadakkan, 2011)].
impairments (Figure 5). Correlations between reduced volume
(Heckers, 2001) of the hippocampus and auditory hallucinations
in schizophrenia indicate the possibility for pathologically intro-
duced non-specific functional LINKs between the postsynapses
that can become the triggering point for an autonomous and
mis-directed train of activity at higher neuronal orders. Surgi-
cal removal of the hippocampus was considered as a treatment
option to reduce delusions in schizophrenia (Mikell et al., 2009),
supporting the view that hippocampal pathologies are capable of
triggering autonomic mis-regulated activities.
Non-specific inter-postsynaptic LINKs occurring at the penul-
timate neuronal order from an oscillating neuronal area can
lead to different consequences. (a) Normally, oscillatory neu-
ronal activity is expected to produce sub-threshold activation
of those neurons at the higher orders that receive fewer EPSPs
than required for spatial or temporal summation capable of
inducing an action potential. When additional EPSPs reach these
sub-threshold activated neurons, it will lead to their autonomic
activation and result in the transmission of activity to higher
neuronal orders, activating many previously formed specific func-
tional LINKs and inducing meaningful hallucinations (Figure 5).
(b) The non-specific inter-postsynaptic LINKs occurring at the
penultimate neuronal order from the oscillating neuronal orders
can also lead to changes in oscillatory neuronal activity (Figure 5)
and are expected to be responsible for changes in consciousness
(Vadakkan, 2010). Such changes in neuronal oscillations in schiz-
ophrenia have been extensively reviewed (Uhlhaas and Singer,
2010). Even though inter-postsynaptic changes have not been
examined, a large number of studies reporting dendritic spine
changes along with gray matter changes in schizophrenia (Bennett,
2011) increase the likelihood of non-specific inter-postsynaptic
functional LINKs.
In summary, (a) non-specific inter-postsynaptic functional
LINK formation can induce a universal effect at the neuronal
orders above the oscillating orders such that no separate func-
tioning areas exist that can identify the hallucinations as unreal.
(b) In the presence of the continuous arrival of activity through the
pathological non-specific inter-postsynaptic mis-LINKs, the sub-
threshold-activated neurons maintained by oscillatory neuronal
activity start firing, re-activating the normal inter-postsynaptic
functional LINKs at higher neuronal orders so that the hallu-
cinations become autonomous in nature. (c) The convincing
sense of reality of the hallucinations indicates that beyond the
origin of autonomous activation of non-specific functional mis-
LINKs, the system is operating by using the normal mechanism
of formation of semblances for memory retrieval, using previ-
ously formed inter-postsynaptic functional LINKs from associa-
tive learning events; but their formation occurs in a wrong context,
inducing hallucinations. (d) The hallucinations are similar to the
perception of sensory stimuli from the environment due to the
inter-postsynaptic mis-LINKs at the early neuronal orders in the
auditory cortex (and not merely the type of internal sensations
occurring at the time of memory retrieval by integration of sem-
blances from specific inter-LINKed postsynapses at higher neu-
ronal orders at which the cue stimulus and item whose memories
are to be retrieved exist).
DELUSIONS OPERATE THROUGH A SIMILAR MECHANISM
A delusion is a belief held with a very strong conviction by the
subject, even in the presence of a counter-argument provided by
a second person. This indicates that there is a compelling inter-
nal sensation experienced by the subject who is perceiving the
delusions and that the subject lacks an operational mechanism
within the remaining nervous system that identifies the internal
sensation of delusions as unreal. The formation of these delu-
sions can be explained as resulting from their autonomous activa-
tions from pathological non-specific inter-postsynaptic functional
LINKs. Since the latter leads to the activation of a non-specific
set of otherwise normal inter-postsynaptic functional LINKs at
higher neuronal orders in the entire nervous system, the subject
autonomously continues to perceive items or events (a) that were
not associatively learned in the past and (b) that were not asso-
ciatively learned from the environment from which their nervous
systems continue to make associations.
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FIGURE 5 | Schematic representation of the effect of non-specific LINKs
between the islets of functionally LINKed postsynapses that can lead to
cognitive dysfunction, changes in oscillating waveforms, and result in
meaningful hallucinations. (A) Cross-section through large number of
postsynapses assuming that they are in the same plane. Thin arrow: single
postsynapse; Thick arrow: islet of LINKed postsynapses. Note that two of the
islets are interconnected in comparison with those shown in Figure 4B. (B)
This figure is modified from Figure 4C. Cross-section through two islets of
LINKed postsynapses I1 and I2 (also shown in Figure 4C) that are
non-specifically LINKed. This results in the formation of a combination of
semblances S1 and S2, changing the conformation of semblances of retrieved
memories (as shown in Figure 4C). Note that the neurons N1 and N2 that
otherwise receive sub-threshold stimuli now start receiving EPSPs from the
islet I1. This leads to the activation of the neurons N1 and N2, resulting in the
activation of islets of functionally LINKed postsynapses I3 and I4, eliciting
semblances (S3 and S4) of previously associatively learned items or events,
producing meaningful hallucinations. Note that background oscillatory
neuronal activity was proposed to result in semblance formation from a large
number of functionally LINKed postsynapses, resulting in C-semblance
responsible for consciousness (Vadakkan, 2010). Non-specific LINK induced
activation of large number of neurons similar to N1 and N2 can lead to a
change in oscillatory neuronal activity (not shown) changing the conformation
of C-semblance (not shown) and produce alterations in conscious perception
of items or events.
REVERSIBLE AND STABILIZABLE MEMBRANE HEMI-FUSION AS A
MECHANISM FOR FUNCTIONAL LINKs
In many locations in the nervous system, the postsynaptic mem-
branes belonging to different neurons are apposed to each other
with minimal visible extracellular matrix volume, especially in
locations where sensory inputs converge; for example, the hip-
pocampi. One of the feasible mechanisms for the generation of
functional LINKs between the postsynaptic membranes is the
formation of reversible membrane hemi-fusion. A large number
of studies have shown reversible hemi-fusion occurring between
biological membranes (Melikyan and Chernomordik, 1997; Cher-
nomordik and Kozlov, 2008; Kozlov et al., 2010). It is reason-
able to expect reversible membrane hemi-fusion between the
postsynapses during associative learning that can later be re-
activated during memory retrieval, resulting in the spread of
activity across the hemi-fused membranes to the second post-
synapse (Figure 6). After one associative learning event, if the
hemi-fused membranes are not reused or re-activated, they will
reverse back to independent membranes. If hemi-fused mem-
brane segments are traversed by proteins and are not reused
or re-activated, they can reverse back to independent mem-
branes once the life of the trans-membrane proteins is over.
If the hypothesis is true, the formation of the non-specific
membrane hemi-fusion should be responsible for the induc-
tion of hallucinations (note: hereafter, inter-postsynaptic func-
tional LINKs and hemi-fused postsynaptic membranes are used
interchangeably).
SUPPORTING EVIDENCE FOR POSTSYNAPTIC MEMBRANE
HEMI-FUSION
Since internal sensations of hallucinations and retrieved memo-
ries are expected to share a common mechanism of operation,
we expect inter-postsynaptic functional LINKs to be observed
as inter-postsynaptic membrane hemi-fusions. Since extensive
research work has already been done in the field of memory,
both functional and structural evidence were examined from the
literature.
Functional evidence
From the studies of patient H.M. (Scoville and Milner, 1957),
it was found that H.M. was unable to make any motor expres-
sion indicative of experiencing the internal sensations of retrieval
of memories of information acquired during a certain period of
time prior to the surgical removal of his hippocampi. Following
this study, experiments were carried out in rodent hippocampi
to study memory. Using hippocampal slices, it was found that
if a brief repetitive stimulation is applied initially at the axonal
regions of the neurons of CA3 layer of neurons (Schaffer col-
laterals), then the application of a regular stimulus at the same
location is sufficient to induce a potentiated effect at the CA3-
CA1 synapses as observed by recording from the CA1 region and
is called long-term potentiation (LTP; Bliss and Lomo, 1973). A
large number of correlations between behavioral motor outputs,
indicative of memory retrieval, and LTP were reported (Mor-
ris et al., 2003; Whitlock et al., 2006). Based on the hypothesis
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FIGURE 6 | Schematic diagrams showing hemi-fusion between the
lipid bilayers of the postsynaptic membranes as one of the possible
mechanisms of formation of functional LINKs between the
postsynaptic membranes (postsynapses or dendritic spines).
(A) Closely located postsynaptic membranes that are simultaneously
activated during associative learning. (B) The boxed region in figure (A) is
enlarged to show adjacently located postsynaptic membrane lipid
bilayers. (C) Cellular changes during associative learning can lead to
postsynaptic membrane hemi-fusion. If not re-activated, hemi-fused
membranes reverse back to independent membranes, making the
hemi-fused state a transient one. (D) A protein molecule is shown
traversing the hemi-fused membrane making the hemi-fused area
temporarily stable, depending on the life-span of the inserted
trans-membrane proteins or their ability to shift away from the
hemi-fused areas by lateral movement. The orientation of N and C
terminal ends of these expected trans-membrane proteins are to be
examined. Note that the reversible nature of the membrane hemi-fusion
is marked by reversible signs between the figures (B–D).
that semblance formation is responsible for the internal sensa-
tion of memories, inter-postsynaptic membranes are expected
to become hemi-fused during both associative learning and LTP
induction. Experimental evidence for membrane hemi-fusion
during associative learning may provide indirect evidence for
the formation of non-specific inter-postsynaptic hemi-fusions in
schizophrenia.
In agreement with the above, postsynaptic membrane fusion
was observed during the induction of LTP by introducing exoge-
nous synaptosomal-associated protein (SNAP) into the postsy-
napses through the cell body of the neuron (Lledo et al., 1998).
Since this postsynaptic fusion occluded further LTP induction and
prior LTP induction independently occluded SNAP-induced LTP
induction, is was reported that postsynaptic membrane fusion
takes place during LTP (Lledo et al., 1998). However, it is not
known where such membrane fusions take place at the postsynap-
tic membrane. Since multiple axons are activated simultaneously
during LTP induction and since many postsynapses of the synapses
at their axonal terminals (presynapses) are likely apposed to each
other, it is reasonable to argue that inter-postsynaptic membrane
hemi-fusion occur during LTP induction. Combined with the
observed correlations between behavioral motor features of mem-
ory and LTP, this provides indirect evidence for the formation
of inter-postsynaptic membrane hemi-fusion during associative
learning.
Structural evidence
To seek structural evidence for postsynaptic membrane fusion,
electron microscopic (EM) images of the synapses from previous
studies were examined. By the time rodents reach adulthood, it is
expected that they have experienced a large number of associative
learning events. Therefore, hemi-fused inter-postsynaptic mem-
branes at various locations in the nervous system are expected to be
found. Even though limited resolution sometimes reduces the view
of the membrane lipid bilayers to only single layers, overlapping
of the adjacent postsynaptic membranes can be observed from the
results of different studies (Burette et al., 2012) and (Harris and
Stevens, 1989; He et al., 1998; Sirvanci et al., 2005) indicating the
possible presence of inter-postsynaptic membrane hemi-fusion at
those locations.
PHOSPHOLIPIDS AND MEMBRANE HEMI-FUSION
The attachment of different molecules at both the Sn-2 posi-
tion and to the phosphoric acid at the Sn-3 position is deter-
mined by the substrate availability as well as sequential activi-
ties of enzyme pairs at these locations; both of these conditions
are essential for switching the side chain fatty acids (Figure 7).
The exchange between fatty acids at the Sn-2 position is car-
ried out by the enzymes phospholipase A2 (PLA2; removes fatty
acid) and acyl transferase (adds fatty acid; Murray et al., 2006)
and the exchange between phosphatidyl choline (PC) and phos-
phatidyl ethanolamine (PE) attached to the phosphatidic acid at
the Sn-3 position is carried out by sequential actions of phos-
pholipase D and acyl transferase enzymes. There is preferential
distribution of arachidonic acid (AA) and docosa-hexaenoic acid
(DHA), both derived from essential fatty acids (EFA), in the
Sn-2 position in neuronal cells (Sugiura et al., 2009). It was
shown that monolayers formed by cone-shaped PE and diacyl
glycerol (DAG) bulge in the direction of the non-polar hydrocar-
bon chains, whereas the inverted cone-shaped lysophosphatidyl
choline (LPC) bulges in the opposite direction (Chernomordik
and Kozlov, 2003). This shows that lipid bilayer composition can
determine the bulging of the apposed membranes and possibly
lead to hemi-fusion. These findings reinforce the argument that
the nature of side chains of phospholipids can determine hemi-
fusion between postsynaptic membranes, either in response to
their simultaneous activation during associative learning or non-
specifically, in the latter case leading to the patho-physiology in
schizophrenia.
OBSERVED CORRELATIONS WITH LIPID METABOLISM
An examination of studies of schizophrenia shows supportive evi-
dence for possible errors in hemi-fusion between the postsynaptic
membranes.
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FIGURE 7 | Structure of lipid membrane and its components. (A) Cell
membrane lipid bilayers where the constituent phospholipid molecules have
their hydrophobic ends tuned toward the interior and hydrophilic ends facing
outside. (B) Two phospholipid molecules facing each other. (C) Structures of
these phospholipid molecules are shown as mirror images. Sn, side chain
number. At the third position, x stands for choline, ethanolamine, inositol, or
serine. *Location of action of phospholipase A2 enzyme. #Location of action
of phospholipase D. Phospholipids are named for the presence of phosphate
group. Their main structural stem is a molecule of glycerol, a 3-carbon alcohol.
The fatty acid side chains may be saturated (contains no double bonds and a
name that ends in -anoic acid) or unsaturated (contains double bonds and a
name that ends in -enoic acid). Unsaturated fatty acid contributes to the
fluidity of the membranes. Double bonds can be introduced at the ∆4, ∆5, ∆6,
and ∆9 positions, but not beyond the ∆9 position (∆ denotes the position of
double bonds from the carboxylic acid terminal; ω denotes the position of
double bonds from the methyl terminal end). Usually the fatty acid chains with
an even number of carbon atoms attach to the first (Sn-1; saturated fatty acids
such as palmitic or stearic acid) and second (Sn-2; unsaturated fatty acids
such as oleic or arachidonic acid) carbons of the glycerol molecule. Linoleic
acid and alpha-linolenic acid are the only essential fatty acids (EFAs) that must
be obtained from the diet. All other fatty acids can be synthesized within the
body. Alternate steps of elongation (by the enzyme elongase) and
desaturation (by ∆ desaturase enzyme) enable the synthesis of
polyunsaturated fatty acids (PUFAs) from EFAs. The Sn-3 position hydroxyl
group bonds with phosphoric acid to form phosphatidic acid that in turn bonds
with an alcohol such as serine, ethanolamine, choline, inositol, and
ethanolamine. When the alcohol is sphingosine, the molecule is called
sphingo-phospholipid. Fatty acids are transported in the blood either by
binding to albumin or in the form of triglycerides associated with lipoproteins.
From lipoprotein triglycerides, the fatty acids are released by the action of
lipoprotein lipase in the endothelial cells of the capillaries (Spector and Yorek,
1985; Ben-Zeev et al., 1990). Lipoprotein lipase levels are found higher in the
hippocampus and neocortex (Ben-Zeev et al., 1990). Choline-containing
phospholipids are preferentially located in the outer layer and phosphatidyl
serine and phosphatidyl ethanolamine-containing phospholipids are located in
the inner layer of the membrane bilayer (Murray et al., 2006). The enzyme
flippases transfer phospholipids to different layers. Membranes also have
cholesterol, cholesterol esters, and protein molecules embedded within them.
Membrane phospholipid change
Essential fatty acid levels were found to be lower in the plasma and
red cell membranes of schizophrenic patients (Horrobin et al.,
1989; Kaiya et al., 1991). Similar findings in the plasma were
found in twins concordant for schizophrenia (Bates et al., 1991).
Furthermore, it was reported that circulating levels of PLA2 activ-
ity are increased in the blood of schizophrenic patients (Gattaz
et al., 1990; Gattaz and Brunner, 1996; Ong et al., 2010). Genetic
abnormalities were also observed in the vicinity of the PLA2 gene
(Hudson et al., 1996). There are reports of an increased rate of
loss of essential polyunsaturated fatty acids (PUFAs) from the Sn-
2 position of phospholipids in schizophrenia (Glen et al., 1994;
Horrobin et al., 1994; Peet et al., 1994). It has also been found that
levels of some of the essential PUFAs (AA and DHA) are reduced
in their red cell membrane phospholipids (Glen et al., 1994; Peet
et al., 1994). Similarly, different tissues were found to be deficient
in essential PUFAs in schizophrenic patients (Yao et al., 1994a,b,
2002; Doris et al., 1998; Assies et al., 2001; Khan et al., 2002; Peet
and Horrobin, 2002; Arvindakshan et al., 2003; Reddy et al., 2004).
Decreased essential PUFA levels were also shown to be correlated
with impaired cognitive functioning in schizophrenic patients
(Sumiyoshi et al., 2008). Based on different correlational findings,
abnormal phospholipids in the membranes were hypothesized in
the patho-physiology of schizophrenia (Horrobin et al., 1994; Gat-
taz and Brunner, 1996; Horrobin, 1998). Later, a large number of
investigations showed support for this view (Glen et al., 1994;
Fenton et al., 2000; Maekawa et al., 2011). Furthermore, magnetic
resonance imaging (MRI) studies have found an increased rate
of phospholipid breakdown in the brain of un-medicated schizo-
phrenics (Pettegrew et al., 1991; Williamson et al., 1996; Bentsen
et al., 2012). The effects of reduced PUFAs in the phospholipids
either by reduced EFA in the diet or by defects in the enzymes
taking part in side chain fatty acid replacements or a combination
of the two is likely to predispose the postsynaptic membranes to
undergo non-specific hemi-fusions.
Essential fatty acids in the diet
A recent randomized, placebo-controlled study showed a signif-
icant effect of long-chain omega-3 fatty acids in preventing the
development of psychotic disorders in adolescents presenting with
the known prodrome for the disease (Amminger et al., 2010).
In one study, the essential PUFA concentrations were positively
related with an improvement of positive symptoms (Sumiyoshi
et al., 2011). Another study carried out by treating schizophre-
nia with EFAs, specifically γ-linolenic acid or dihomogamma-
linolenic acid, along with factors for EFA metabolism such as zinc,
vitamins C, B6, and niacin, showed substantial improvement in
symptoms along with an elevation in red cell membrane EFAs
(Vaddadi, 1992). Furthermore, a blood marker of EFA deficiency,
the triene: tetraene ratio (Lee et al., 1993) was found decreased
in schizophrenics (Assies et al., 2001). These findings raise the
possibility that if the limiting EFAs are not obtained through food,
fatty acids in the Sn-2 position may get replaced (Figure 5) with
saturated fatty acids, especially in the setting of increased PLA2
enzyme. A deficiency of EFA in the diet can lead to the replace-
ment of their derivatives with non-essential polyenoic acids at
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the Sn-2 position in phospholipids (Murray et al., 2006). The fatty
acid compositional change in the phospholipids of the membranes
may lead to non-specific hemi-fusion between the postsynapses,
a possible stable low-energy state. It is possible that through the
replacement of fatty acids both at Sn-2 and Sn-3 positions, EFA
supplementation may lead to the incorporation of long-chain
PUFAs and reverse the pathology in schizophrenia. Even though
treatment with EFA may not reverse previously hemi-fused mem-
branes that are traversed by trans-membrane proteins, it may halt
the formation of further non-specific inter-postsynaptic mem-
brane hemi-fusions (Amminger et al., 2010; Sumiyoshi et al.,
2011).
Linkage analysis
A large number of linkage analysis studies have shown puta-
tive candidate genes whose protein products are associated with
lipid metabolism in schizophrenic patients and their family mem-
bers (Moises et al., 1995; Pulver et al., 1995; Straub et al., 1997;
Blouin et al., 1998; Hovatta et al., 1998; Shaw et al., 1998; Barnes
et al., 1999; Brzustowicz et al., 1999; Gurling et al., 1999; Mors
and Ewald, 1999; Riley and Williamson, 2000; Table 2). Among
these, micro-deletion of chromosome 22q11 results in the devel-
opment of a form of schizophrenia among 30% of children with
this deletion (Karayiorgou et al., 2010). These multiple associa-
tions may indicate their role in maintaining normal phospholipid
composition; defects in these chromosomes in combination with
dietary deficiencies may initiate the formation of non-specific
inter-postsynaptic hemi-fusions.
EXPLANATION FOR THE REMAINING FEATURES OF
SCHIZOPHRENIA
COGNITIVE IMPAIRMENT
It is thought that the disability of schizophrenia results more from
under-recognized and treatment-resistant cognitive deficits than
from more visible treatment-sensitive positive symptoms (Harvey
et al., 2010). Data from the Dunedin birth cohort studies (Walsh
et al., 2008) indicate that intelligence quotient (IQ) is reduced early
and persistently in children who eventually develop schizophrenia
(Li et al., 2007). Furthermore, it has been found that reduced
working memory and poor cognitive control are the core features
that lead to long-term morbidity and poor functional outcomes in
schizophrenia (Hyman and Fenton, 2003). Abnormal functioning
of the left temporal lobe is observed in schizophrenia (Shenton
et al., 1992). Two meta-analyses (Lawrie and Abukmeil, 1998; Nel-
son et al., 1998) and one large cohort study (Gothelf et al., 2000)
have shown that the hippocampus is smaller in schizophrenic
patients than controls by approximately 5%. Imaging studies have
shown hippocampal volume reduction and abnormal levels of hip-
pocampal activity at rest and during the motor outputs associated
with memory retrieval (Heckers, 2001). Pathological changes at
the prefrontal cortex (Kraepelin, 1919) and hippocampus (Bogerts
et al., 1985; Harrison, 2004) were reported in schizophrenia.
Working memory
It is thought that a reduction in working memory may be the
best predictor of the psychotic phase of schizophrenia (Coyle,
2006). Based on the neuro-developmental disorder view of schiz-
ophrenia, cognitive impairment starts to manifest during the
stage two of the disease (McGorry et al., 2008; Insel, 2010).
Based on the present work, working memory uses the maxi-
mum number of specific newly hemi-fused postsynaptic mem-
branes to induce a maximum of specific semblances for mem-
ory. Non-specific postsynaptic membrane hemi-fusions increase
non-specific semblances at these locations. Since functional
LINKs occurring at the penultimate orders from the oscillat-
ing neuronal orders can activate sub-threshold-activated neu-
rons, the resulting non-specific semblances can reduce working
memory.
Table 2 | Chromosome locations of some of the genes involved in lipid metabolism that are associated with schizophrenia.
Locations of mutations in
schizophrenic families
Proteins involved in the metabolism
of phospholipid and fatty acids
Chromosome locations
of their genes
2p25-p21 (Moises et al., 1995) Apolipoprotein B 2p24
11q22-q23 (Riley and Williamson, 2000) Apolipoprotein A-IV 11q23
1q22-q23 (Shaw et al., 1998) Apolipoprotein A-II 1q21–1q23
16q22 (Shaw et al., 1998) Lecithin: cholesterol acyl transferase 16q22.1
8p21-p23 (Pulver et al., 1995; Straub et al., 1997; Blouin et al., 1998;
Brzustowicz et al., 1999; Gurling et al., 1999; Mors and Ewald, 1999)
Lipoprotein lipase 8p21–22
7q11 (Blouin et al., 1998) Fatty acid transport protein 7q11.2
9q34.3 (Riley and Williamson, 2000) Carnitine acetyl transferase 9q34.1
11q14-24 (Gurling et al., 1999) Carnitine palmitoyl transferase-I 11q13.1–13.5
2q21 (Barnes et al., 1999) Acyl coenzyme A binding protein 2q12–q21
9p23-p21 (Moises et al., 1995) Phospholipase A2 activating protein 9p21
9q32 (Barnes et al., 1999) Cyclooxygenase-1 9q32–33.3
20p12 (Moises et al., 1995) Phospholipase C, Beta 4 20p12
20q13 (Barnes et al., 1999) Phospholipase C, Gamma 1 20q12–q13.1
22q11-q13 (Pulver et al., 1995, 22q (Hovatta et al., 1998) Phospholipase A2, Group VI 22q13.1
Chromosome locations of some of the genes whose proteins are involved in various stages of the fatty acid transport, phospholipid side chain replacements, and
inter-conversion of different lipoproteins are shown.
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NMDA receptor antagonism leads to schizophrenia-like symptoms
N -methyl-d-aspartate receptor antibody encephalitis induced by
auto-antibodies to NR1/NR2B heteromers of the NMDA receptors
manifests as severe memory defects and schizophrenia-like symp-
toms of hallucinations (Coyle, 2006; Dalmau et al., 2008). Further-
more, a significant reduction in kynurenine 3-mono-oxygenase
enzyme that metabolizes kynurenic acid, an antagonist of NMDA,
is reported in schizophrenia patients (Wonodi et al., 2011). Based
on the present work, an acute reduction in NMDA activity attenu-
ates neurotransmission at certain excitatory synapses, resulting in a
reduced ability to re-activate functional LINKs,and alters neuronal
oscillations, leading to cognitive defects and schizophrenia-like
symptoms.
Dopamine, memory, and LTP
Based on the present hypothesis, the finding that dopamine pro-
motes motivation-induced learning (Wang et al., 2004) can be
attributed to dopamine’s role in functional LINK formation.
Therefore, dopamine antagonists are likely to exhibit an oppo-
site effect: reducing cognitive abilities. In an earlier section, we
explained how LTP induction may result in the formation of a large
number of inter-postsynaptic functional LINKs. Since dopamine
is implicated in long-term memory storage (Rossato et al., 2009)
and has been found to be necessary for late-LTP at the CA3-CA1
synapses of the hippocampi (Matthies et al., 1997; Swanson-Park
et al., 1999; Yang et al., 2002; O’Carroll and Morris, 2004), it is pos-
sible that dopamine augments or stabilizes the inter-postsynaptic
functional LINKs.
EFFECT OF DOPA RECEPTOR-BLOCKING ANTIPSYCHOTICS ON
HALLUCINATIONS
Based on the present work, factors that promote the forma-
tion of inter-postsynaptic functional LINKs are likely to augment
learning; those that inhibit are likely to attenuate learning. The
effect of dopamine on both motivation-induced learning (Wang
et al., 2004) and on the persistence of long-term memory stor-
age (Rossato et al., 2009) suggests the possibility that dopamine
promotes and maintains inter-postsynaptic functional LINKs. We
can extend this view to argue that hyper-dopaminergic con-
ditions may lead to the formation of additional non-specific
functional LINKs during spontaneous activity of dopaminer-
gic neurons in the ventral tegmental area, which was shown
to produce symptoms of psychosis (Liddle et al., 2000; Lodge
and Grace, 2007). This may also explain why schizophrenia is
viewed as a dopamine disorder based on the psychosis-inducing
effects of dopamine-releasing drugs such as amphetamine, and
the antipsychotic efficacy of drugs that block the dopamine D2
receptors (Okubo et al., 1997). Supporting evidence was also
observed in animal experiments. D2 receptor over-expressing
transgenic mice (Castner et al., 2000) that were bred to test the
dopamine hypothesis (Sedvall and Farde, 1995; Okubo et al.,
1997) showed substantial behavioral changes related to prefrontal
cortical function. Dopamine’s role in modulating neurotrans-
mission in the prefrontal cortex has also been demonstrated
(Burmeister et al., 2008; Stefansson et al., 2008). Furthermore,
micro-deletion of the catechol o-methyl transferase (COMT) gene
causes deficiency of its protein, leading to reduced catabolism of
dopamine and further leading to the latter’s accumulation and
resulting in an increased susceptibility to schizophrenia (Egan
et al., 2001).
In separate studies, both reward and aversive stimuli were
shown to cause the bursting of dopaminergic neurons (Ljungberg
et al., 1992; Schultz, 2007; Bromberg-Martin et al., 2010), releasing
dopamine at their nerve terminals. Electro-physiological record-
ings have demonstrated the activation of the human substantia
nigra or ventral tegmental areas by associative reward stimuli
(Zaghloul et al., 2009). A similar observation was made for one-
trial encoding of the location of the escape platform in a water
maze (O’Carroll et al., 2006). Furthermore, intra-hippocampal
infusion of the D1/D5 dopamine antagonist just before encoding
was shown to cause impaired behavioral motor outputs (Bethus
et al., 2010). Further support comes from reports that amphiphilic
psychotropic drugs stimulate cellular lipid biosynthesis (Vik-Mo
et al., 2009) through the activation of the sterol regulatory element-
binding protein transcription factors, regulating the expression
of many genes during fatty acid synthesis. Thus, a mechanis-
tic explanation is possible to define the role of dopamine in
inducing and maintaining specific inter-postsynaptic membrane
hemi-fusion.
RELATION WITH CONSCIOUSNESS
Fundamental features of schizophrenia have been observed to
manifest across all the domains of consciousness: subjective expe-
rience, expression, cognition, affect, behavior, and will (Parnas,
2011). It is viewed that what defines a mental illness is its effect
on the conscious representational experience (Anscombe, 1987;
Graham and Stephens, 2007). Moreover, schizophrenia is thought
to involve a profound alteration in the structures (frameworks) of
subjectivity (consciousness), and to manifest in self-relation and
in the relation to the world (Urfer-Parnas et al., 2010). Further-
more, it is thought that schizophrenic patients lack control over
mental processes so that when emotions and intuitions are not
brought into focus, the individual loses his or her sense of self
(Krabbendam and van Os, 2005). It is reasonable to argue that a
mechanism that can explain the formation of internal sensations
should also be able to explain how this basic mechanism can be
expanded to involve different domains of consciousness. In this
regard, baseline neuronal oscillations in the hippocampus and
cortex and background sensory inputs are postulated to induce
re-activations of a large number of functional LINKs, inducing a
net non-specific semblance called C-semblance, which is respon-
sible for normal consciousness (Vadakkan, 2010). According to the
present framework, when non-specific hemi-fusion between the
postsynaptic membranes takes place at certain neuronal orders,
the alterations in the oscillatory waveforms at the higher neuronal
orders change the conformation of C-semblance. The impairment
of stimulus-induced gamma synchronization across neocortical
networks (Schiller, 1992), and an impaired response to Gestalt
(Spencer et al., 2003), and auditory and sensory stimuli (Green
et al., 1999; Kwon et al., 1999) were reported in schizophrenic
patients, which is in agreement with the present framework. It
is possible that the non-specific functional LINKs distort the
oscillatory waveforms and the resulting C-semblances altering the
conscious state.
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NEGATIVE SYMPTOMS
Non-specific inter-postsynaptic functional LINKs can lead to
autonomous activity that can stimulate non-specific sets of neu-
rons in the motor cortex, causing non-purposeful motor outflow,
and resulting in the symptoms of catatonia. Trains of unmatched
semblances may explain disorganized hallucinations. As the num-
ber of non-specific functional LINKs increases, it will result in
bizarre non-meaningful hallucinations.
EXPLANATION FOR THE OBSERVED CONCORDANCE RATES
Even though studies of generations of families and twins have
demonstrated the high heritability of schizophrenia (Purcell et al.,
2009; Stefansson et al., 2009; Ettinger et al., 2012), the concor-
dance rate in monozygotic twins affected with the disease is
found to be roughly 45–50% (Kallmann, 1938; Kety, 1987; McGuf-
fin and Gottesman, 1999). If schizophrenia is caused entirely by
genetic abnormalities, the concordance rate in monozygotic twins
who have almost identical genes is expected to be nearly 100%.
The concordance rate in dizygotic twins is nearly 15%, which
is about the same as for other siblings (Kallmann, 1938). The
rate of schizophrenia was found to be higher among the biolog-
ical relatives of adopted children who developed schizophrenia
than among adopted children who were normal (Heston, 1970;
Rosenthal et al., 1971), indicating that related protein products
can undergo certain processes that predispose them to the disease
process.
The concordance rate of nearly 50% among monozygotic twins
may be explained as follows. The present work has shown how
the replacement of PUFAs with saturated fatty acids at the Sn-2
position of the phospholipids may facilitate non-specific hemi-
fusion between the postsynaptic membranes. Multiple genetic loci
code for proteins in the lipid metabolic pathways, some of which
are enzymes (Table 2); these loci are implicated in the etiology
of schizophrenia. Autosomal recessive inheritance of enzymes is
expected to result in heterozygotes with reduced expression of
the protein from a single functional allele of the gene. These het-
erozygotes remain symptom-free, provided they receive sufficient
EFA in the diet. However, a dietary deficiency of EFA can lead
to reduced incorporation of PUFA at the Sn-2 position, which in
turn may produce non-specific membrane hemi-fusion. Since the
probability of PUFAs being made and incorporated into the mem-
brane phospholipids ranges from 0 to 100, an average value of 50%
may explain the nearly 50% concordance rate among monozygotic
twins.
Another mechanism also needs mention. Schizophrenic
patients have shown global hypo-methylation within the DNA,
which is known to reverse with neuroleptic medications (Melas
et al., 2012). Reduced methylation of DNA increases gene expres-
sion, possibly to compensate for the reduced expression of certain
proteins. While this may be beneficial for maximizing expres-
sion from single alleles in heterozygotes, it can lead to the
over-expression of certain other proteins that may adversely
affect the disease process. For example, PLA2 over-expression in
schizophrenic patients (Gattaz et al., 1990; Gattaz and Brunner,
1996) removes DHA and AA from Sn-2 position of phospholipids.
In the case of reduced dietary EFA, it can lead to reduced
synthesis of PUFA, further leading to the incorporation of sat-
urated fatty acids at the Sn-2 position of the phospholipids, which
can predispose the membranes to non-specific hemi-fusion.
INITIAL MANIFESTATION IN TEENAGE GROUPS
Psychosis emerges in late adolescence or early adulthood, with
peak incidence between ages 18 and 25, when the prefrontal
cortex continues its development. Longitudinal neuro-imaging
studies have demonstrated changes in gray matter density until the
mid-twenties, with the prefrontal cortex being the last to mature
(Rakic et al., 1986; Lewis and Gonzalez-Burgos, 2008; Hashimoto
et al., 2009). Dopaminergic innervation of the prefrontal cortex
increases markedly during adolescence (Woodberry et al., 2008).
A report from a 45 year follow up of a Copenhagen birth cohort
demonstrates that adults with schizophrenia have a history of
delayed developmental milestones in the first year followed by
delayed maturation (Reichenberg et al., 2010). Even though a dis-
ruption of the genes that are either associated (Niwa et al., 2010)
or not associated (Tan et al., 2007; Colantuoni et al., 2008; Nakata
et al., 2009) with neuronal development is implicated in schiz-
ophrenia, the role of this disruption in disease development is
not known. From a structural point of view, the “mis-wiring”
hypothesis of schizophrenia is based on the aberrant synaptic
pruning during adolescence (Huttenlocher, 1979; Feinberg, 1982;
Faludi and Mirnics, 2011) and the loss of parvalbumin-containing
interneurons that can even lead to changes in neuronal oscillations
(Perry et al., 1979; Lewis et al., 2005; Lodge et al., 2009). The func-
tional mis-wiring can lead to the effect of the same final common
pathway produced by non-specific inter-postsynaptic membrane
hemi-fusions by activating non-specific sets of normal functional
LINKs at the higher neuronal orders, manifesting the symptoms
of schizophrenia.
During the pre-teen age when the nervous system is exposed to
a large number of associative learning events, the size of the islets
of functionally LINKed postsynapses increases. Pathological non-
specific LINKs at this stage will have a lesser effect since the islets are
small and are surrounded mostly by individual postsynapses, per-
mitting the non-specific LINKs to induce non-specific semblances
only at those individual postsynapses. The biochemical pathways
that maintain the lipid membrane composition are crucial at this
stage. It was reported that lipoprotein lipase is inhibited by ovarian
and testicular steroids and during puberty (Bucher et al., 1997),
possibly restricting the ability to re-organize the lipid composi-
tion. This is important especially in the presence of a combination
of dietary lack of EFAs and the heterozygous nature of expression
of proteins in the lipid synthesis and re-organization pathways.
As teenagers continue to grow and associatively learn, the size of
the islets of inter-postsynaptic functional LINKs increases. Dur-
ing this period, any membrane compositional change can increase
the probability of non-specific membrane hemi-fusion between
the islets, resulting in the activation of an increasing number of
non-specific neurons, changes the oscillatory waveforms, lead-
ing to the internal sensations of hallucinations and cognitive
defects.
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GLIAL PATHOLOGIES MAY ACT THROUGH THE FINAL
COMMON PATHWAY
Mechanisms that can induce the lateral spread of activity by non-
neuronal pathologies can also lead to disease symptoms and can be
explained by the present work. Changes in glial-neuronal interac-
tions possible in oligodendroglial pathologies that are reported
as white matter changes in schizophrenia (Bartzokis, 2011;
Takahashi et al., 2011) may alter the relative speed of conduc-
tion in certain fibers, resulting in the simultaneous activation of
a non-specific set of postsynapses inducing non-specific func-
tional LINKs that can initiate autonomous meaningful halluci-
nations as explained in the earlier sections. In addition, myelin
lipid changes may reflect lipid membrane compositional changes
that can provoke non-specific inter-postsynaptic membrane hemi-
fusion, especially in the setting of reduced expression of those
proteins required for lipid transport, synthesis of essential PUFAs,
and phospholipid membrane side chain replacements. In addi-
tion, extracellular matrix compositional changes (Berretta, 2012)
may promote the formation of non-specific functional LINKs,
generating the disease symptoms.
FUTURE IMPLICATIONS
Work toward examining the ultra-structural changes of the post-
synaptic membranes is needed to test the possibility of membrane
hemi-fusion as a mechanism of inter-postsynaptic functional
LINK formation. Since EM examination uses sections with a thick-
ness of 5× 10−8 m, whereas the average size of a dendritic spine
is nearly 4–5× 10−7 m, obtaining a large number of (nearly 100)
serial EM sections is necessary to examine the entire surface of a
dendritic spine to visualize membrane hemi-fusion. We anticipate
hemi-fusions only at very short lengths of the apposed postsy-
naptic membranes, necessitating a thorough examination of the
entire dendritic spine’s (postsynapse’s) membrane bilayer. Since it
is possible that inter-postsynaptic hemi-fusion can take place even
farther away from the synaptic cleft, a large-scale re-construction
of EM sections is required to visualize such hemi-fusion. The prob-
ability of finding hemi-fusion is high at regions where sensory
inputs converge; for example, the hippocampus.
Adolescents with the prodrome (Yung et al., 2008; Henry et al.,
2010), who have not yet presented with symptoms of schizo-
phrenia, were shown to have a 405-fold increased risk of devel-
oping the disease compared to the general population (Cannon
et al., 2008). Using a randomized double-blind placebo-controlled
study, it was observed that EFA treatment prevented the devel-
opment of the disease process in this group (Amminger et al.,
2010). These results are explained by the role of dietary EFA in
determining the postsynaptic membrane composition, in reducing
abnormal membrane hemi-fusion, and in preventing conversion
to psychosis. Based on the present work, how can we reverse an
established disease? The traversing proteins at the non-specifically
hemi-fused postsynapses need to be removed first. Identifying such
proteins may lead to the development of methods to remove them
from specific locations. This, combined with EFA supplementa-
tion and long-term educational programs will be required for
functional rehabilitation.
CONCLUSION
The present work provides the framework of a mechanism for the
clinical features of schizophrenia, a disease found to be associated
with a multitude of genetic and environmental factors. Non-
specific hemi-fusion between postsynaptic membranes at certain
neuronal orders is hypothesized to be the final common path that
can induce autonomous meaningful hallucinations and cognitive
defects. We expect that various other pathways that are impli-
cated in schizophrenia, which are not mentioned in this work,
can find suitable entry points into the present framework. The
final path explains the implications of the involvement of both
NMDA and dopamine neurotransmitters. By examining the for-
mation of basic units of internal sensations resulting from the
lateral entry of activity at the synaptic level, it was possible to
attribute the diverse features of auditory hallucinations, cogni-
tive impairment, and defects in consciousness to pathological
structural changes; these changes also serve as an explanation
for the beneficial effect of EFA reported from a randomized
double-blinded control trial (Amminger et al., 2010). Internal sen-
sations hypothesized as semblances induced by the lateral entry
of activity at the inter-postsynaptic functional LINKs provide a
testable mechanism, though testing-methods are yet to be devel-
oped. Even though the present structure-function mechanism is
compatible with available experimental data, it must be consid-
ered unproven until verified against confirmatory experimental
results.
ACKNOWLEDGMENTS
I acknowledge support from the Neurosearch Center in Toronto. I
thank the reviewers for their valuable comments and suggestions.
REFERENCES
Abeles, M. (1991). Corticonics: Neural
Circuits of the Cerebral Cortex. Cam-
bridge: Cambridge University Press.
Amminger, G. P., Schafer, M. R., Papa-
georgiou, K., Klier, C. M., Cotton, S.
M., Harrigan, S. M., et al. (2010).
Long-chain omega-3 fatty acids for
indicated prevention of psychotic
disorders: a randomized, placebo-
controlled trial. Arch. Gen. Psychia-
try 67, 146–154.
Anscombe, R. (1987). The disorder
of consciousness in schizophrenia.
Schizophr. Bull. 13, 241–260.
Arvindakshan, M., Sitasawad, S., Deb-
sikdar, V., Ghate, M., Evans, D.,
Horrobin, D. F., et al. (2003).
Essential polyunsaturated fatty acid
and lipid peroxide levels in never-
medicated and medicated schizo-
phrenia patients. Biol. Psychiatry 53,
56–64.
Assies, J., Lieverse, R., Vreken, P.,
Wanders, R. J., Dingemans, P. M.,
and Linszen, D. H. (2001). Sig-
nificantly reduced docosahexaenoic
and docosapentaenoic acid con-
centrations in erythrocyte mem-
branes from schizophrenic patients
compared with a carefully matched
control group. Biol. Psychiatry 49,
510–522.
Bancaud, J., Brunet-Bourgin, F., Chau-
vel, P., and Halgren, E. (1994).
Anatomical origin of deja vu and
vivid ‘memories’ in human tempo-
ral lobe epilepsy. Brain 117(Pt 1),
71–90.
Barnes, R. I., Wilson, R., Holcomb, J.,
Kizer, A., Filbey, M., and Bowcock,
G. D. L. (1999). Interaction between
four loci may increase susceptibility
to schizophrenia. Mol. Psychiatry 4,
S31.
Bartzokis, G. (2011). Neuroglialphar-
macology: white matter pathophys-
iologies and psychiatric treatments.
Front. Biosci. 16, 2695–2733.
Bates, C., Horrobin, D. F., and Ells, K.
(1991). Fatty acids in plasma phos-
pholipids and cholesterol esters from
identical twins concordant and dis-
cordant for schizophrenia. Schizo-
phr. Res. 6, 1–7.
Behrendt, R. P. (2010). Contribution
of hippocampal region CA3 to con-
sciousness and schizophrenic hallu-
cinations. Neurosci. Biobehav. Rev.
34, 1121–1136.
Frontiers in Psychiatry | Schizophrenia December 2012 | Volume 3 | Article 108 | 12
Vadakkan A structure-function mechanism for schizophrenia
Bennett, M. R. (2011). Schizophrenia:
susceptibility genes, dendritic-spine
pathology and gray matter loss.Prog.
Neurobiol. 95, 275–300.
Bentsen, H., Solberg, D. K., Refsum,
H., and Bohmer, T. (2012). Clin-
ical and biochemical validation of
two endophenotypes of schizophre-
nia defined by levels of polyunsatu-
rated fatty acids in red blood cells.
Prostaglandins Leukot. Essent. Fatty
Acids 87, 35–41.
Ben-Zeev, O., Doolittle, M. H., Singh,
N., Chang, C. H., and Schotz, M. C.
(1990). Synthesis and regulation of
lipoprotein lipase in the hippocam-
pus. J. Lipid Res. 31, 1307–1313.
Berretta, S. (2012). Extracellular matrix
abnormalities in schizophrenia.
Neuropharmacology 62, 1584–1597.
Bethus, I., Tse, D., and Morris, R. G.
(2010). Dopamine and memory:
modulation of the persistence
of memory for novel hippocam-
pal NMDA receptor-dependent
paired associates. J. Neurosci. 30,
1610–1618.
Birchwood, M., Meaden, A., Trower, P.,
Gilbert, P., and Plaistow, J. (2000).
The power and omnipotence of
voices: subordination and entrap-
ment by voices and significant oth-
ers. Psychol. Med. 30, 337–344.
Bliss, T. V., and Lomo, T. (1973).
Long-lasting potentiation of synap-
tic transmission in the dentate area
of the anaesthetized rabbit following
stimulation of the perforant path. J.
Physiol. (Lond.) 232, 331–356.
Blouin, J. L., Dombroski, B. A., Nath,
S. K., Lasseter, V. K., Wolyniec, P.
S., Nestadt, G., et al. (1998). Schiz-
ophrenia susceptibility loci on chro-
mosomes 13q32 and 8p21. Nat.
Genet. 20, 70–73.
Bogerts, B., Meertz, E., and Schonfeldt-
Bausch, R. (1985). Basal ganglia and
limbic system pathology in schizo-
phrenia. A morphometric study of
brain volume and shrinkage. Arch.
Gen. Psychiatry 42, 784–791.
Bromberg-Martin, E. S., Matsumoto,
M., and Hikosaka, O. (2010).
Dopamine in motivational control:
rewarding, aversive, and alerting.
Neuron 68, 815–834.
Brzustowicz, L. M., Honer, W. G., Chow,
E. W., Little, D., Hogan, J., Hodgkin-
son, K., et al. (1999). Linkage of
familial schizophrenia to chromo-
some 13q32. Am. J. Hum. Genet. 65,
1096–1103.
Bucher, H., Rampini, S., James, R. W.,
Pometta, D., Funke, H., Wiebusch,
H., et al. (1997). Marked changes
of lipid levels during puberty in a
patient with lipoprotein lipase defi-
ciency. Eur. J. Pediatr. 156, 121–125.
Burette, A. C., Lesperance, T., Crum, J.,
Martone, M., Volkmann, N., Ellis-
man, M. H., et al. (2012). Elec-
tron tomographic analysis of synap-
tic ultrastructure. J. Comp. Neurol.
520, 2697–2711.
Burmeister, M., McInnis, M. G., and
Zollner, S. (2008). Psychiatric genet-
ics: progress amid controversy. Nat.
Rev. Genet. 9, 527–540.
Buzsaki, G. (1996). The hippocampo-
neocortical dialogue. Cereb. Cortex
6, 81–92.
Cannon, T. D., Cadenhead, K., Corn-
blatt, B., Woods, S. W., Addington,
J., Walker, E., et al. (2008). Predic-
tion of psychosis in youth at high
clinical risk: a multisite longitudinal
study in North America. Arch. Gen.
Psychiatry 65, 28–37.
Cardoso, E. F., Fregni, F., Maia, F. M.,
Melo, L. M., Sato, J. R., Cruz,A. C. Jr.,
et al. (2010). Abnormal visual activa-
tion in Parkinson’s disease patients.
Mov. Disord. 25, 1590–596.
Castner, S. A., Williams, G. V., and
Goldman-Rakic, P. S. (2000). Rever-
sal of antipsychotic-induced work-
ing memory deficits by short-term
dopamine D1 receptor stimulation.
Science 287, 2020–2022.
Chernomordik, L. V., and Kozlov, M.
M. (2003). Protein-lipid interplay
in fusion and fission of biological
membranes.Annu. Rev. Biochem. 72,
175–207.
Chernomordik, L. V., and Kozlov, M.
M. (2008). Mechanics of membrane
fusion. Nat. Struct. Mol. Biol. 15,
675–683.
Colantuoni, C., Hyde, T. M., Mitkus, S.,
Joseph, A., Sartorius, L., Aguirre, C.,
et al. (2008). Age-related changes in
the expression of schizophrenia sus-
ceptibility genes in the human pre-
frontal cortex. Brain Struct. Funct.
213, 255–271.
Coyle, J. T. (2006). Glutamate and schiz-
ophrenia: beyond the dopamine
hypothesis. Cell. Mol. Neurobiol. 26,
365–384.
Dalmau, J., Gleichman, A. J., Hughes,
E. G., Rossi, J. E., Peng, X., Lai, M.,
et al. (2008). Anti-NMDA-receptor
encephalitis: case series and analysis
of the effects of antibodies. Lancet
Neurol. 7, 1091–1098.
David, C. N., Greenstein, D., Clasen, L.,
Gochman, P., Miller, R., Tossell, J. W.,
et al. (2011). Childhood onset schiz-
ophrenia: high rate of visual halluci-
nations. J. Am. Acad. Child Adolesc.
Psychiatry 50, 681–686 e3.
Davis, F. A., Bergen, D., Schauf, C.,
McDonald, I., and Deutsch, W.
(1976). Movement phosphenes in
optic neuritis: a new clinical sign.
Neurology 26, 1100–1104.
Doris, A. B., Wahle, K., MacDonald,
A., Morris, S., Coffey, I., Muir, W.,
et al. (1998). Red cell membrane
fatty acids, cytosolic phospholipase-
A2 and schizophrenia. Schizophr.
Res. 31, 185–196.
Egan, M. F., Goldberg, T. E., Kolachana,
B. S., Callicott, J. H., Mazzanti, C.
M., Straub, R. E., et al. (2001). Effect
of COMT Val108/158 Met genotype
on frontal lobe function and risk for
schizophrenia. Proc. Natl. Acad. Sci.
U.S.A. 98, 6917–6922.
Ettinger, U., Schmechtig, A.,
Toulopoulou, T., Borg, C., Orrells,
C., Owens, S., et al. (2012). Pre-
frontal and striatal volumes in
monozygotic twins concordant
and discordant for schizophrenia.
Schizophr. Bull. 38, 192–203.
Faludi, G., and Mirnics, K. (2011).
Synaptic changes in the brain of sub-
jects with schizophrenia. Int. J. Dev.
Neurosci. 29, 305–309.
Feinberg, I. (1982). Schizophrenia:
caused by a fault in programmed
synaptic elimination during adoles-
cence? J. Psychiatr. Res. 17, 319–334.
Fenton, W. S., Hibbeln, J., and Knable,
M. (2000). Essential fatty acids, lipid
membrane abnormalities, and the
diagnosis and treatment of schizo-
phrenia. Biol. Psychiatry 47, 8–21.
Gattaz, W. F., and Brunner, J.
(1996). Phospholipase A2 and
the hypofrontality hypothesis
of schizophrenia. Prostaglandins
Leukot. Essent. Fatty Acids 55,
109–113.
Gattaz, W. F., Hubner, C. V., Nevalainen,
T. J., Thuren, T., and Kinnunen, P. K.
(1990). Increased serum phospholi-
pase A2 activity in schizophrenia: a
replication study.Biol. Psychiatry 28,
495–501.
Gelbard-Sagiv, H., Mukamel, R., Harel,
M., Malach, R., and Fried, I. (2008).
Internally generated reactivation of
single neurons in human hippocam-
pus during free recall. Science 322,
96–101.
Glen, A. I., Glen, E. M., Horrobin, D. F.,
Vaddadi, K. S., Spellman, M., Morse-
Fisher, N., et al. (1994). A red cell
membrane abnormality in a sub-
group of schizophrenic patients: evi-
dence for two diseases. Schizophr.
Res. 12, 53–61.
Gothelf, D., Soreni, N., Nachman, R.
P., Tyano, S., Hiss, Y., Reiner, O.,
et al. (2000). Evidence for the
involvement of the hippocampus in
the pathophysiology of schizophre-
nia. Eur. Neuropsychopharmacol. 10,
389–395.
Graham, G., and Stephens, G. L. (2007).
“Psychopathology: minding mental
illness,” in Philosophy of Psychology
and Cognitive Science, ed. P. Thagard
(Amsterdam: Elsevier), 339–368.
Green, M. F., Nuechterlein, K. H., Bre-
itmeyer, B., and Mintz, J. (1999).
Backward masking in unmedicated
schizophrenic patients in psychotic
remission: possible reflection of
aberrant cortical oscillation. Am. J.
Psychiatry 156, 1367–1373.
Gurling, H. M., Kalsi, G., Blaveri, E.,
McQuillin, A., Read, T., Murphy, P.,
et al. (1999). Initial genome wide
parametric genetic linkage analy-
sis of the schizophrenia and schiz-
ophrenia spectrum disorders finds
LOD scores above 3.00 on four
chromosomes at 1q22-23, 5q22-35,
8p21-23 and 11q14-24. A further
LOD above 3.00 at 4q21-31 was
found with a single family. Mol.
Psychiatry 4, S4.
Harris, K. M., and Stevens, J. K. (1989).
Dendritic spines of CA 1 pyramidal
cells in the rat hippocampus: serial
electron microscopy with reference
to their biophysical characteristics. J.
Neurosci. 9, 2982–2997.
Harrison, P. J. (2004). The hippocam-
pus in schizophrenia: a review
of the neuropathological evidence
and its pathophysiological impli-
cations. Psychopharmacology (Berl.)
174, 151–162.
Harvey, P. D., Reichenberg, A., Bowie, C.
R., Patterson, T. L., and Heaton, R. K.
(2010). The course of neuropsycho-
logical performance and functional
capacity in older patients with schiz-
ophrenia: influences of previous his-
tory of long-term institutional stay.
Biol. Psychiatry 67, 933–939.
Hashimoto, T., Nguyen, Q. L., Rotaru,
D., Keenan, T., Arion, D., Beneyto,
M., et al. (2009). Protracted devel-
opmental trajectories of GABAA
receptor alpha1 and alpha2 subunit
expression in primate prefrontal cor-
tex. Biol. Psychiatry 65, 1015–1023.
He, Y., Janssen, W. G., and Morrison,
J. H. (1998). Synaptic coexistence of
AMPA and NMDA receptors in the
rat hippocampus: a postembedding
immunogold study. J. Neurosci. Res.
54, 444–449.
Heckers, S. (2001). Neuroimaging stud-
ies of the hippocampus in schizo-
phrenia. Hippocampus 11, 520–528.
Henry, L. P., Amminger, G. P., Har-
ris, M. G., Yuen, H. P., Harrigan,
S. M., Prosser, A. L., et al. (2010).
The EPPIC follow-up study of first-
episode psychosis: longer-term clin-
ical and functional outcome 7 years
after index admission. J. Clin. Psy-
chiatry 71, 716–728.
Heston, L. L. (1970). The genetics of
schizophrenic and schizoid disease.
Science 167, 249–256.
www.frontiersin.org December 2012 | Volume 3 | Article 108 | 13
Vadakkan A structure-function mechanism for schizophrenia
Holden, C. (2003). Neuroscience.
Deconstructing schizophrenia.
Science 299, 333–335.
Holroyd, S., Rabins, P. V., Finkelstein, D.,
Nicholson, M. C., Chase, G. A., and
Wisniewski, S. C. (1992). Visual hal-
lucinations in patients with macular
degeneration. Am. J. Psychiatry 149,
1701–1706.
Horrobin, D. F. (1998). The membrane
phospholipid hypothesis as a bio-
chemical basis for the neurodevel-
opmental concept of schizophrenia.
Schizophr. Res. 30, 193–208.
Horrobin, D. F., Glen,A. I., and Vaddadi,
K. (1994). The membrane hypothe-
sis of schizophrenia. Schizophr. Res.
13, 195–207.
Horrobin, D. F., Manku, M. S., Morse-
Fisher, N., Vaddadi, K. S., Courtney,
P., Glen, A. I., et al. (1989). Essential
fatty acids in plasma phospholipids
in schizophrenics. Biol. Psychiatry
25, 562–568.
Hovatta, I., Lichtermann, D., and Juvo-
nen, H. (1998). Linkage analysis of
putative schizophrenia gene candi-
date regions on chromosomes 3p,5q,
6p, 8p, 20p and 22q in a population-
based sampled Finnish family set.
Mol. Psychiatry 3, 452–457.
Hudson, C. J., Kennedy, J. L., Gotowiec,
A., Lin, A., King, N., Gojtan, K.,
et al. (1996). Genetic variant near
cytosolic phospholipase A2 associ-
ated with schizophrenia. Schizophr.
Res. 21, 111–116.
Huttenlocher, P. R. (1979). Synaptic
density in human frontal cortex –
developmental changes and effects
of aging. Brain Res. 163, 195–205.
Hyman, S. E., and Fenton, W. S. (2003).
Medicine. What are the right tar-
gets for psychopharmacology? Sci-
ence 299, 350–351.
Insel, T. R. (2010). Rethinking schizo-
phrenia. Nature 468, 187–193.
Kaiya, H., Horrobin, D. F., Manku, M.
S., and Fisher, N. M. (1991). Essen-
tial and other fatty acids in plasma in
schizophrenics and normal individ-
uals from Japan. Biol. Psychiatry 30,
357–362.
Kallmann, F. J. (1938). The Genetics of
Schizophrenia. New York: Augustin.
Karayiorgou, M., Simon, T. J., and
Gogos, J. A. (2010). 22q11.2
Microdeletions: linking DNA
structural variation to brain dys-
function and schizophrenia. Nat.
Rev. Neurosci. 11, 402–416.
Kety, S. S. (1987). The significance
of genetic factors in the etiology
of schizophrenia: results from the
national study of adoptees in Den-
mark. J. Psychiatr. Res. 21, 423–429.
Khan, M. M., Evans, D. R., Gunna, V.,
Scheffer, R. E., Parikh, V. V., and
Mahadik, S. P. (2002). Reduced ery-
throcyte membrane essential fatty
acids and increased lipid perox-
ides in schizophrenia at the never-
medicated first-episode of psychosis
and after years of treatment with
antipsychotics. Schizophr. Res. 58,
1–10.
Kirkpatrick, B., Buchanan, R. W., Ross,
D. E., and Carpenter,W. T. Jr. (2001).
A separate disease within the syn-
drome of schizophrenia. Arch. Gen.
Psychiatry 58, 165–171.
Kozlov, M. M., McMahon, H. T.,
and Chernomordik, L. V. (2010).
Protein-driven membrane stresses in
fusion and fission. Trends Biochem.
Sci. 35, 699–706.
Krabbendam, L., and van Os, J. (2005).
Schizophrenia and urbanicity: a
major environmental influence –
conditional on genetic risk. Schizo-
phr. Bull. 31, 795–799.
Kraepelin, E. (1919). Dementia Praecox
and Paraphrenia. New York: Robert
E. Krieger Publishing Co.Inc.
Kwon, J. S., O’Donnell, B. F., Wallen-
stein, G. V., Greene, R. W., Hirayasu,
Y., Nestor, P. G., et al. (1999).
Gamma frequency-range abnormal-
ities to auditory stimulation in schiz-
ophrenia. Arch. Gen. Psychiatry 56,
1001–1005.
Lawrie, S. M., and Abukmeil, S. S.
(1998). Brain abnormality in schiz-
ophrenia. A systematic and quan-
titative review of volumetric mag-
netic resonance imaging studies. Br.
J. Psychiatry 172, 110–120.
Lee, E. J., Simmer, K., and Gibson, R.
A. (1993). Essential fatty acid defi-
ciency in parenterally fed preterm
infants. J. Paediatr. Child Health 29,
51–55.
Lewis, D. A., and Gonzalez-Burgos, G.
(2008). Neuroplasticity of neocorti-
cal circuits in schizophrenia. Neu-
ropsychopharmacology 33, 141–165.
Lewis, D. A., Hashimoto, T., and Volk, D.
W. (2005). Cortical inhibitory neu-
rons and schizophrenia. Nat. Rev.
Neurosci. 6, 312–324.
Li, W., Zhou, Y., Jentsch, J. D.,
Brown, R. A., Tian, X., Ehninger,
D., et al. (2007). Specific develop-
mental disruption of disrupted-in-
schizophrenia-1 function results in
schizophrenia-related phenotypes in
mice. Proc. Natl. Acad. Sci. U.S.A.
104, 18280–18285.
Liddle, P. F., Lane, C. J., and Ngan,
E. T. (2000). Immediate effects
of risperidone on cortico-striato-
thalamic loops and the hippocam-
pus. Br. J. Psychiatry 177, 402–407.
Linn, E. L. (1977). Verbal auditory hal-
lucinations: mind, self, and society.
J. Nerv. Ment. Dis. 164, 8–17.
Ljungberg, T., Apicella, P., and Schultz,
W. (1992). Responses of monkey
dopamine neurons during learning
of behavioral reactions. J. Neuro-
physiol. 67, 145–163.
Lledo, P. M., Zhang, X., Sudhof, T.
C., Malenka, R. C., and Nicoll, R.
A. (1998). Postsynaptic membrane
fusion and long-term potentiation.
Science 279, 399–403.
Llinas, R. R., and Pare, D. (1991). Of
dreaming and wakefulness. Neuro-
science 44, 521–535.
Lodge, D. J., Behrens, M. M., and Grace,
A. A. (2009). A loss of parvalbumin-
containing interneurons is associ-
ated with diminished oscillatory
activity in an animal model of schiz-
ophrenia. J. Neurosci. 29, 2344–2354.
Lodge, D. J., and Grace, A. A. (2007).
Aberrant hippocampal activity
underlies the dopamine dysreg-
ulation in an animal model of
schizophrenia. J. Neurosci. 27,
11424–11430.
Maekawa, M., Owada, Y., and
Yoshikawa, T. (2011). Role of
polyunsaturated fatty acids and
fatty acid binding protein in the
pathogenesis of schizophrenia. Curr.
Pharm. Des. 17, 168–175.
Matthies, H., Becker, A., Schroeder,
H., Kraus, J., Hollt, V., and Krug,
M. (1997). Dopamine D1-deficient
mutant mice do not express the
late phase of hippocampal long-
term potentiation. Neuroreport 8,
3533–3535.
McGorry, P. D., Yung, A. R., Bechdolf,
A., and Amminger, P. (2008). Back
to the future: predicting and reshap-
ing the course of psychotic disorder.
Arch. Gen. Psychiatry 65, 25–27.
McGuffin, P., and Gottesman, II. (1999).
Risk factors for schizophrenia. N.
Engl. J. Med. 341, 370–371; author
reply 372.
Melas, P. A., Rogdaki, M., Ösby,
U., Schalling, M., Lavebratt, C.,
and Ekström, T. J. (2012). Epige-
netic aberrations in leukocytes of
patients with schizophrenia: associ-
ation of global DNA methylation
with antipsychotic drug treatment
and disease onset. FASEB J. 27, 2012.
Melikyan, G. B., and Chernomordik,
L. V. (1997). Membrane rearrange-
ments in fusion mediated by
viral proteins. Trends Microbiol. 5,
349–355.
Mikell, C. B., McKhann, G. M., Segal,
S., McGovern, R. A., Wallenstein,
M. B., and Moore, H. (2009). The
hippocampus and nucleus accum-
bens as potential therapeutic tar-
gets for neurosurgical intervention
in schizophrenia. Stereotact. Funct.
Neurosurg. 87, 256–265.
Moises, H. W.,Yang, L., Kristbjarnarson,
H., Wiese, C., Byerley, W., Maccia-
rdi, F., et al. (1995). An international
two-stage genome-wide search for
schizophrenia susceptibility genes.
Nat. Genet. 11, 321–324.
Morris, R. G., Moser, E. I., Riedel, G.,
Martin, S. J., Sandin, J., Day, M.,
et al. (2003). Elements of a neuro-
biological theory of the hippocam-
pus: the role of activity-dependent
synaptic plasticity in memory. Phi-
los. Trans. R. Soc. Lond. B Biol. Sci.
358, 773–786.
Mors, O., and Ewald, H. (1999).
Schizophrenia co-occurring with
autosomal cytogenetic abnormali-
ties. Mol. Psychiatry 4, S40.
Murray, R. K., Granner, D. K., and Rod-
well, V. W. (2006). Harper’s Illus-
trated Biochemistry, 28th Edn, 203,
212, 427. New York: The McGraw-
Hill Companies Inc.
Nakata, K., Lipska, B. K., Hyde, T. M.,
Ye, T., Newburn, E. N., Morita, Y., et
al. (2009). DISC1 splice variants are
upregulated in schizophrenia and
associated with risk polymorphisms.
Proc. Natl. Acad. Sci. U.S.A. 106,
15873–15878.
Nelson, M. D., Saykin, A. J., Flashman,
L. A., and Riordan, H. J. (1998).
Hippocampal volume reduction in
schizophrenia as assessed by mag-
netic resonance imaging: a meta-
analytic study. Arch. Gen. Psychiatry
55, 433–440.
Niwa, M., Kamiya, A., Murai, R., Kubo,
K., Gruber, A. J., Tomita, K., et
al. (2010). Knockdown of DISC1
by in utero gene transfer disturbs
postnatal dopaminergic maturation
in the frontal cortex and leads to
adult behavioral deficits. Neuron 65,
480–489.
O’Brien, J. T., Firbank, M. J., Mosimann,
U. P., Burn, D. J., and McKeith, I. G.
(2005). Change in perfusion, hallu-
cinations and fluctuations in con-
sciousness in dementia with Lewy
bodies. Psychiatry Res. 139, 79–88.
O’Carroll, C. M., Martin, S. J., Sandin,
J., Frenguelli, B., and Morris, R.
G. (2006). Dopaminergic modula-
tion of the persistence of one-trial
hippocampus-dependent memory.
Learn. Mem. 13, 760–769.
O’Carroll, C. M., and Morris, R.
G. (2004). Heterosynaptic co-
activation of glutamatergic and
dopaminergic afferents is required
to induce persistent long-term
potentiation. Neuropharmacology
47, 324–332.
Oertel, V., Rotarska-Jagiela, A., van de
Ven, V.G., Haenschel, C., Maurer,
K., and Linden, D. E. (2007). Visual
hallucinations in schizophrenia
Frontiers in Psychiatry | Schizophrenia December 2012 | Volume 3 | Article 108 | 14
Vadakkan A structure-function mechanism for schizophrenia
investigated with functional mag-
netic resonance imaging. Psychiatry
Res. 156, 269–273.
Okubo, Y., Suhara, T., Suzuki, K.,
Kobayashi, K., Inoue, O., Terasaki,
O., et al. (1997). Decreased pre-
frontal dopamine D1 receptors in
schizophrenia revealed by PET.
Nature 385, 634–636.
Ong, W. Y., Farooqui, T., and Farooqui,
A. A. (2010). Involvement of cytoso-
lic phospholipase A(2), calcium
independent phospholipase A(2)
and plasmalogen selective phospho-
lipase A(2) in neurodegenerative and
neuropsychiatric conditions. Curr.
Med. Chem. 17, 2746–2763.
Panayiotopoulos, C. P. (1994). Ele-
mentary visual hallucinations in
migraine and epilepsy. J. Neurol.
Neurosurg. Psychiatr. 57, 1371–1374.
Parnas, J. (2011). A disappearing
heritage: the clinical core of schiz-
ophrenia. Schizophr. Bull. 37,
1121–1130.
Peet, M., and Horrobin, D. F. (2002).
A dose-ranging exploratory
study of the effects of ethyl-
eicosapentaenoate in patients with
persistent schizophrenic symptoms.
J. Psychiatr. Res. 36, 7–18.
Peet, M., Laugharne, J. D., Horrobin,
D. F., and Reynolds, G. P. (1994).
Arachidonic acid: a common link in
the biology of schizophrenia? Arch.
Gen. Psychiatry 51, 665–666.
Perry, T. L., Kish, S. J., Buchanan, J.,
and Hansen, S. (1979). Gamma-
aminobutyric-acid deficiency in
brain of schizophrenic patients.
Lancet 1, 237–239.
Pettegrew, J. W., Keshavan, M. S., Pan-
chalingam, K., Strychor, S., Kaplan,
D. B., Tretta, M. G., et al. (1991).
Alterations in brain high-energy
phosphate and membrane phospho-
lipid metabolism in first-episode,
drug-naive schizophrenics. A pilot
study of the dorsal prefrontal cor-
tex by in vivo phosphorus 31 nuclear
magnetic resonance spectroscopy.
Arch. Gen. Psychiatry 48, 563–568.
Pulver, A. E., Lasseter, V. K., Kasch, L.,
Wolyniec, P., Nestadt, G., Blouin, J.
L., et al. (1995). Schizophrenia: a
genome scan targets chromosomes
3p and 8p as potential sites of sus-
ceptibility genes. Am. J. Med. Genet.
60, 252–260.
Purcell, S. M., Wray, N. R., Stone, J. L.,
Visscher, P. M., O’Donovan, M. C.,
Sullivan, P. F., et al. (2009). Com-
mon polygenic variation contributes
to risk of schizophrenia and bipolar
disorder. Nature 460, 748–752.
Rakic, P., Bourgeois, J. P., Ecken-
hoff, M. F., Zecevic, N., and
Goldman-Rakic, P. S. (1986).
Concurrent overproduction of
synapses in diverse regions of the
primate cerebral cortex. Science 232,
232–235.
Reddy, R. D., Keshavan, M. S.,
and Yao, J. K. (2004). Reduced
red blood cell membrane essen-
tial polyunsaturated fatty acids
in first episode schizophrenia at
neuroleptic-naive baseline. Schizo-
phr. Bull. 30, 901–911.
Reichenberg, A., Caspi, A., Harrington,
H., Houts, R., Keefe, R. S., Mur-
ray, R. M., et al. (2010). Static and
dynamic cognitive deficits in child-
hood preceding adult schizophrenia:
a 30-year study. Am. J. Psychiatry
167, 160–169.
Reijmers, L. G., Perkins, B. L., Matsuo,
N., and Mayford, M. (2007). Local-
ization of a stable neural correlate
of associative memory. Science 317,
1230–1233.
Riley, B., and Williamson, R. (2000).
Sane genetics for schizophrenia.Nat.
Med. 6, 253–255.
Rosenthal, D., Wender, P. H., Kety, S.
S., Welner, J., and Schulsinger, F.
(1971). The adopted-away offspring
of schizophrenics. Am. J. Psychiatry
128, 307–311.
Rossato, J. I., Bevilaqua, L. R., Izquierdo,
I., Medina, J. H., and Cammarota, M.
(2009). Dopamine controls persis-
tence of long-term memory storage.
Science 325, 1017–1120.
Schiller, F. (1992). Paul Broca. Oxford:
Oxford University Press.
Schmidt, E. M., Bak, M. J., Hambrecht,
F. T., Kufta, C. V., O’Rourke, D. K.,
and Vallabhanath, P. (1996). Feasi-
bility of a visual prosthesis for the
blind based on intracortical micros-
timulation of the visual cortex.Brain
119(Pt 2), 507–522.
Schultz, W. (2007). Multiple dopamine
functions at different time courses.
Annu. Rev. Neurosci. 30, 259–288.
Scoville, W. B., and Milner, B. (1957).
Loss of recent memory after bilat-
eral hippocampal lesions. J. Neurol.
Neurosurg. Psychiatr. 20, 11–21.
Sedvall, G., and Farde, L. (1995). Chem-
ical brain anatomy in schizophrenia.
Lancet 346, 743–749.
Selimbeyoglu, A., and Parvizi, J.
(2010). Electrical stimulation
of the human brain: percep-
tual and behavioral phenomena
reported in the old and new liter-
ature. Front. Hum. Neurosci. 4:46.
doi:10.3389/fnhum.2010.00046
Shaw, S. H., Kelly, M., Smith, A. B.,
Shields, G., Hopkins, P. J., Loftus,
J., et al. (1998). A genome-wide
search for schizophrenia susceptibil-
ity genes. Am. J. Med. Genet. 81,
364–376.
Shenton, M. E., Kikinis, R., Jolesz, F. A.,
Pollak, S. D., LeMay, M., Wible, C.
G., et al. (1992). Abnormalities of
the left temporal lobe and thought
disorder in schizophrenia. A quan-
titative magnetic resonance imaging
study. N. Engl. J. Med. 327, 604–612.
Shergill, S. S., Brammer, M. J.,
Williams, S. C., Murray, R. M., and
McGuire, P. K. (2000). Mapping
auditory hallucinations in schizo-
phrenia using functional magnetic
resonance imaging. Arch. Gen. Psy-
chiatry 57, 1033–1038.
Siatkowski, R. M., Zimmer, B., and
Rosenberg, P. R. (1990). The
Charles Bonnet syndrome. Visual
perceptive dysfunction in sensory
deprivation. J. Clin. Neuroophthal-
mol. 10, 215–218.
Sirvanci, S., Meshul, C. K., Onat, F.,
and San, T. (2005). Glutamate and
GABA immunocytochemical elec-
tron microscopy in the hippocam-
pal dentate gyrus of normal and
genetic absence epilepsy rats. Brain
Res. 1053, 108–115.
Spector, A. A., and Yorek, M. A. (1985).
Membrane lipid composition and
cellular function. J. Lipid Res. 26,
1015–1035.
Spencer, K. M., Nestor, P. G.,
Niznikiewicz, M. A., Salisbury,
D. F., Shenton, M. E., and McCarley,
R. W. (2003). Abnormal neural
synchrony in schizophrenia. J.
Neurosci. 23, 7407–7411.
Stefansson, H., Ophoff, R. A., Steinberg,
S., Andreassen, O. A., Cichon, S.,
Rujescu, D., et al. (2009). Common
variants conferring risk of schizo-
phrenia. Nature 460, 744–747.
Stefansson, H., Rujescu, D., Cichon,
S., Pietilainen, O. P., Ingason, A.,
Steinberg, S., et al. (2008). Large
recurrent microdeletions associated
with schizophrenia. Nature 455,
232–236.
Straub, R. E., MacLean, C. J., O’Neill,
F. A., Walsh, D., and Kendler, K.
S. (1997). Support for a possible
schizophrenia vulnerability locus in
region 5q22-31 in Irish families.Mol.
Psychiatry 2, 148–155.
Sugiura, Y., Konishi, Y., Zaima, N., Kaji-
hara, S., Nakanishi, H., Taguchi,
R., et al. (2009). Visualization
of the cell-selective distribution
of PUFA-containing phosphatidyl-
cholines in mouse brain by imaging
mass spectrometry. J. Lipid Res. 50,
1776–1788.
Sumiyoshi, T., Higuchi, Y., Matsui, M.,
Itoh, H., Uehara, T., Itoh, T., et al.
(2011). Membrane fatty acid levels
as a predictor of treatment response
in chronic schizophrenia. Psychiatry
Res. 186, 23–27.
Sumiyoshi, T., Matsui, M., Itoh, H.,
Higuchi, Y., Arai, H., Takamiya, C.,
et al. (2008). Essential polyunsatu-
rated fatty acids and social cognition
in schizophrenia.PsychiatryRes. 157,
87–93.
Swanson-Park, J. L., Coussens, C. M.,
Mason-Parker, S. E., Raymond, C.
R., Hargreaves, E. L., Dragunow,
M., et al. (1999). A double disso-
ciation within the hippocampus of
dopamine D1/D5 receptor and beta-
adrenergic receptor contributions to
the persistence of long-term poten-
tiation. Neuroscience 92, 485–497.
Takahashi, N., Sakurai, T., Davis, K.
L., and Buxbaum, J. D. (2011).
Linking oligodendrocyte and myelin
dysfunction to neurocircuitry
abnormalities in schizophrenia.
Prog. Neurobiol. 93, 13–24.
Tan, W., Wang, Y., Gold, B., Chen,
J., Dean, M., Harrison, P. J., et
al. (2007). Molecular cloning of a
brain-specific, developmentally reg-
ulated neuregulin 1 (NRG1) iso-
form and identification of a func-
tional promoter variant associated
with schizophrenia. J. Biol. Chem.
282, 24343–24351.
Thagard, P. (2008). Mental illness from
the perspective of theoretical neu-
roscience. Perspect. Biol. Med. 51,
335–352.
Tulving, E. (2002). Episodic memory:
from mind to brain. Annu. Rev.
Psychol. 53, 1–25.
Tye, K. M., Stuber, G. D., de Rid-
der, B., Bonci, A., and Janak, P.
H. (2008). Rapid strengthening of
thalamo-amygdala synapses medi-
ates cue-reward learning. Nature
453, 1253–1257.
Uhlhaas, P. J., and Singer, W. (2010).
Abnormal neural oscillations and
synchrony in schizophrenia. Nat.
Rev. Neurosci. 11, 100–113.
Urfer-Parnas, A., Mortensen, E. L., and
Parnas, J. (2010). Core of schiz-
ophrenia: estrangement, dementia
or neurocognitive disorder? Psy-
chopathology 43, 300–311.
Vadakkan, K. I. (2009). Delusions, cog-
nitive impairment and the thera-
peutic effect of dopamine recep-
tor antagonists in schizophrenia –
an explanation through the sem-
blance hypothesis of memory. Soci-
ety for Neuroscience Annual Confer-
ence, abstr. 644.3/U18, Chicago.
Vadakkan, K. I. (2010). Frame-
work of consciousness from the
semblance of activity at func-
tionally LINKed postsynaptic
membranes. Front. Psychol. 1:168.
doi:10.3389/fpsyg.2010.00168
Vadakkan, K. I. (2011). Processing
semblances induced through
www.frontiersin.org December 2012 | Volume 3 | Article 108 | 15
Vadakkan A structure-function mechanism for schizophrenia
inter-postsynaptic functional
LINKs, presumed biological par-
allels of K-lines proposed for
building artificial intelligence.
Front. Neuroeng. 4:8. doi:10.3389/
fneng.2011.00008
Vaddadi, K. S. (1992). Use of gamma-
linolenic acid in the treatment of
schizophrenia and tardive dyskine-
sia. Prostaglandins Leukot. Essent.
Fatty Acids 46, 67–70.
van Os, J., Kenis, G., and Rutten,
B. P. (2010). The environment
and schizophrenia. Nature 468,
203–212.
Vignal, J. P., Maillard, L., McGonigal,
A., and Chauvel, P. (2007). The
dreamy state: hallucinations of auto-
biographic memory evoked by tem-
poral lobe stimulations and seizures.
Brain 130, 88–99.
Vik-Mo, A. O., Ferno, J., Skrede, S., and
Steen, V. M. (2009). Psychotropic
drugs up-regulate the expression
of cholesterol transport proteins
including ApoE in cultured human
CNS and liver cells.BMCPharmacol.
9:10. doi:10.1186/1471-2210-9-10
Walsh, T., McClellan, J. M., McCarthy,
S. E., Addington, A. M., Pierce, S. B.,
Cooper, G. M., et al. (2008). Rare
structural variants disrupt multiple
genes in neurodevelopmental path-
ways in schizophrenia. Science 320,
539–543.
Wang, M., Vijayraghavan, S., and
Goldman-Rakic, P. S. (2004).
Selective D2 receptor actions on
the functional circuitry of working
memory. Science 303, 853–856.
Whitlock, J. R., Heynen, A. J., Shuler, M.
G., and Bear, M. F. (2006). Learn-
ing induces long-term potentiation
in the hippocampus. Science 313,
1093–1097.
Williamson, P. C., Brauer, M., Leonard,
S., Thompson, T., and Drost, D.
(1996). 31P magnetic resonance
spectroscopy studies in schizophre-
nia. Prostaglandins Leukot. Essent.
Fatty Acids 55, 115–118.
Wonodi, I., Stine, O. C., Sathyasaikumar,
K. V., Roberts, R. C., Mitchell, B. D.,
Hong, L. E., et al. (2011). Downregu-
lated kynurenine 3-monooxygenase
gene expression and enzyme activity
in schizophrenia and genetic associ-
ation with schizophrenia endophe-
notypes. Arch. Gen. Psychiatry 68,
665–674.
Woodberry, K. A., Giuliano, A. J.,
and Seidman, L. J. (2008). Premor-
bid IQ in schizophrenia: a meta-
analytic review. Am. J. Psychiatry
165, 579–587.
Yang, H. W., Lin, Y. W., Yen, C. D.,
and Min, M. Y. (2002). Change
in bi-directional plasticity at CA1
synapses in hippocampal slices taken
from 6-hydroxydopamine-treated
rats: the role of endogenous nor-
epinephrine. Eur. J. Neurosci. 16,
1117–1128.
Yao, J., Stanley, J. A., Reddy, R.
D., Keshavan, M. S., and Pet-
tegrew, J. W. (2002). Correla-
tions between peripheral polyun-
saturated fatty acid content and
in vivo membrane phospholipid
metabolites. Biol. Psychiatry 52,
823–830.
Yao, J. K., van Kammen, D. P., and
Gurklis, J. (1994a). Red blood cell
membrane dynamics in schizophre-
nia. III. Correlation of fatty acid
abnormalities with clinical mea-
sures. Schizophr. Res. 13, 227–232.
Yao, J. K., van Kammen, D. P., and
Welker, J. A. (1994b). Red blood
cell membrane dynamics in schizo-
phrenia. II. Fatty acid composition.
Schizophr. Res. 13, 217–226.
Young, W. B., Heros, D. O., Ehren-
berg, B. L., and Hedges, T. R.
III. (1989). Metamorphopsia and
palinopsia. Association with peri-
odic lateralized epileptiform dis-
charges in a patient with malig-
nant astrocytoma. Arch. Neurol. 46,
20–22.
Yung, A. R., Nelson, B., Stanford, C.,
Simmons, M. B., Cosgrave, E. M.,
Killackey, E., et al. (2008). Valida-
tion of “prodromal”criteria to detect
individuals at ultra high risk of
psychosis: 2 year follow-up. Schizo-
phr. Res. 105, 10–17.
Zaghloul, K. A., Blanco, J. A., Weide-
mann, C. T., McGill, K., Jaggi, J. L.,
Baltuch, G. H., et al. (2009). Human
substantia nigra neurons encode
unexpected financial rewards. Sci-
ence 323, 1496–1499.
Conflict of Interest Statement: The
author declares that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 01 August 2012; accepted: 01
December 2012; published online: 28
December 2012.
Citation: Vadakkan KI (2012) A
structure-function mechanism for schiz-
ophrenia. Front. Psychiatry 3:108. doi:
10.3389/fpsyt.2012.00108
This article was submitted to Frontiers in
Schizophrenia, a specialty of Frontiers in
Psychiatry.
Copyright © 2012 Vadakkan. This is an
open-access article distributed under the
terms of the Creative Commons Attribu-
tion License, which permits use, distrib-
ution and reproduction in other forums,
provided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
Frontiers in Psychiatry | Schizophrenia December 2012 | Volume 3 | Article 108 | 16
